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Birth weight is an important indicator for predicting newborn baby’s health. Particular 
toxic elements: lead (Pb), arsenic (As), mercury (Hg), cadmium (Cd) have ability to cross 
the transplacental barrier and effect the fetal growth and development. These toxic 
elements exposure during pregnancy have been associated with negative birth outcomes 
like low birth weight (LBW). 
Objectives 
The objective of this study was to conduct the assessment of selected toxic elements (Pb, 
Hg, As and Cd) in the mother’s blood sample during the gestational period and their effects 
on birth weight.   
Methods 
A subset of 282 pregnant women who delivered their babies from the North Norwegian 
Mother-and-Child Study (MISA) was included in our study. The participants completed a 
detailed self-reported information questionnaire supplied by MISA study. Blood samples 
were collected during the 2nd trimester (P1) and 3rd postpartum (P2) in different regions 
of Northern Norway, and were analyzed for four selected toxic elements. Both univariate 
and multivariate analyses were conducted, birth weight was adjusted for a range of 
potential confounders.  
Results 
In multivariable model, we revealed that an increasing maternal blood Pb concentration 
negatively influenced birth weight in baby girls (p-value=0.009). Moreover, elevated 
maternal blood Cd concentration increased the chances of reduced birth weight in baby 
boys (p-value=0.045) when adjusted for alone. We also found all the toxic elements 
peaked at P2 except Hg which is at the P1 time period. 
Conclusion  
The present study found a significant inverse association between maternal Pb 
concentration and birth weight in female neonates only. The negative correlation of 
maternal Cd concentration with birth weight is observed in male neonates but not in 
female neonates. These significant correlations confirm the potential for sex response 
differences to Pb and Cd exposure. 
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1 Introduction 
 
Birth weight is an important indicator for predicting newborn baby’s health. It is widely 
accepted that both low birth weight (LBW) and high birth weight (macrosomia) can have 
either short or long-term effects on a child's health in later life [1] . Under this assumption 
of interconnection, birth weight is used to rationalize variants in infant mortality and later 
morbidity, and is also used as an intermediate health endpoint in itself [2]. Of concern, 
some particular long-term chemical or toxic elements (like Cadmium (Cd), mercury (Hg), 
lead (Pb), arsenic (As)) exposure during pregnancy have been associated with negative 
birth outcomes like low birth weight (LBW), prematurity, and small-for-gestational age 
(SGA) increase the risk of neonatal morbidity and mortality [3-5]. During pregnancy, 
placenta acts not only as protective organ for fetus but also as a good indicator for 
dimension of toxic elements exposure. Most of the elements have the ability to pass 
transplacental barrier and accumulate in the choice of organs in fetal side[6]. 
Over the centuries, toxic elements, also known as non-essential metals, are recognized for 
their potential toxicity and easy access to enter the food web. Cadmium (Cd), mercury 
(Hg), lead (Pb), arsenic (As) are the most common toxic elements according to the WHO’s 
most common public health concern chemicals or chemicals of groups[7].  CERCLA 
(Comprehensive Environmental Response, Compensation, and Liability Act) ranks As as 
no.1, Pb as no.2, Hg as no.3 and Cd as no.7  [8]. These elements’ feature some properties 
like:  
•    Persistence: sustain in the nature under different occurrences for many years 
and mortifies very slowly. 
•    Bioaccumulation: concentration increases over the times within a living 
individual, this feature is very suitable for the human body. With the time or 
development of age the concentrations also get higher. 
•    Biomagnification: concentration goes higher along the food chain means single 
from top of the food chain contains the highest concentration, this property is very 
common in the food web in the ocean. The members of a top in the chain contains 
a high amount of toxic substance than rest. However, toxic metals could be toxic 
even lower concentration [9].  
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Toxic metals appear or are discharged into nature and afterward, eventually enter the 
food chain making this a primary route for human exposure [7]. Toxic elements exposures 
during sensitive windows of development, mainly gestational period and in the first few 
years of life, could have a role in chronic disease development [10]. Lifestyles, particularly 
the diet, play a crucial role in personal exposure to environmental toxicants [11].  Cd, Hg, 
As and Pb have garnered a significant attention because of their widespread exposure 
worldwide. Fetal exposure through trans-placental passage, evidence of fetotoxicity, 
multi-organ adverse effects, and ability to interact with the genome and the epigenome 
[12]. These adverse effects are imperative threats for human life as well as future 
generation. Thus, maternal exposure is our particular concern because of contaminant 
concentration during pregnancy, which can give us an indication of the potential risk to 
the developing fetus [13]. Moreover, fetuses and young children are the most vulnerable 
to these environmental contaminations. Specifically, concerns are negative birth 
outcomes like low birth weight and neurodevelopmental disorders with later 
developmental and other health consequences [13-15]. In a research work, the authors 
demonstrate that Pb can mobilize from maternal bone into plasma to meet up the extra 
demand during pregnancy period, without detectable changes in whole blood Pb. So this 
changes suggest that bone Pb remains in bone for years to decades, even after maternal 
external Pb exposure has declined, it has equal ability to affect the newborn [16]. Smoking, 
a valuable source for Cd, affects differently during pregnancy than nonsmoker group [17]. 
Since, maternal smoking during pregnancy causes the stimulation of maternal 
catecholamine release; as a result, uterine vasoconstriction occurs. Consequently, less 
blood supply causes less fetal growth and development[18]. As, a potential toxicant, 
which has adverse effects on birth outcomes (birth weight, birth length, head and chest 
circumferences) due to prolong maternal exposure during pregnancy [19]. A cohort study 
about maternal low levels exposure of Hg during pregnancy period reveals about 
children’s serious and permanent neurobehavioral effect in later life [20].   In this thesis, 
we are going to study the relationship between fetal birth weight and maternal status of 
toxic elements in blood. Measurement of these toxic elements through the pregnancy and 
postnatal time trends in blood have been shown to reflect the changes in the maternal 
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1.1 Objectives and the research questions of the study 
 
In this study, we attempt to conduct an estimation of levels of selected toxic elements in 
the mother’s blood sample and their effects on fetal outcome among the north 
Norwegian mothers. More specifically, the study objectives are:  
•    To conduct the assessment of selected toxic elements (Pb, Hg, As and Cd) in 
the mother’s blood sample during the gestational period and their effects on birth 
weight.  
 
The following research questions are formulated to meet the research objectives:  
1. Evaluation of selected toxic elements (Pb, Hg, As and Cd) and their effects on 
birth weight. 
2. To find a best model between P1 and P2 to build a multivariable regression 
model. 
 
The MISA study[21] is aimed to conduct for measurement of concentrations of 
environmental contaminants in expecting mothers, (and in their new babies) and their 
effects on birth outcomes like birth weight. These expecting mothers are from the three 
most northern counties of Norway, namely Nordland, Troms, and Finnmark. 
 
1.2 Organization of the thesis  
 
This thesis comprises of four chapters.  
The first chapter introduces detail information about toxic elements including sources, 
distribution in maternal body, fetal transfer etc. and their effects on birth weight. 
Furthermore, this chapter includes information about birth weight and its influencing 
factors, progress of pregnancy, placental development, and mechanism of transfer for 
different toxic elements through placenta. The research questions (the objectives and 
justifications for the study) have also been described in this chapter.  
Chapter two includes relevant material and methods and shows a brief description of the 
study area and study population. Dependent and different independent variables which 
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are significantly associated with our study and a brief description of statistical analysis 
have been demonstrated in this chapter.  
Chapter three contains the results of this study: the different demographic factors and 
their values. In addition, different birth outcomes and maternal blood toxic elements are 
also evaluated. Furthermore, the relationship between birth weight and the effects of 
selected toxic elements and their relationships with the gender of the baby are also 
described in this chapter. We used several regression methods which include univariate 
linear regression, and multiple linear regression.  
Chapter four concludes the thesis with a review of the themes discussed in the previous 
chapters and summarizing and analyzing the findings. It has also justified the thesis by 
discussing different strength and limitation of the study.  
1.3 Background 
 
1.3.1 Selected toxic elements, sources and their health effects 
1.3.1.1 Human Exposure 
 
The primary exposure for human for these elements are through skin, inhalation, and 
drinking water or mainly by ingestion of food. Among the food, especially the seafood is a 
good source for toxic elements like Hg, As, Cd etc. Even at low levels, toxic elements may 
cause various types of diseases and disabilities, where especially growing fetus and 
newborn babies are designated as vulnerable groups. However, it is quite difficult to show 
the negative effects of different elements separately, because of the variety of toxicants 
and similar source. Here is a brief description of toxic elements, their properties, and how 
they affect to the birth weight of the newborn babies. 
1.3.2 Lead 
Sources 
Lead (Pb) is a natural occurring neurotoxic metal which is found widespread in the 
surroundings. The removal of Pb from water pipes, paint and food cans, as well as a ban 
on Pb additives to petrol in most countries, has reduced exposure to Pb in recent years. 
Industrial activities such as mining, smelting, Pb shot manufacture and battery 
manufacture and recycling are still of concern [22]. Particular food, especially game (like 
duck, goose, woodcock, elk, reindeer, etc.), hunted by leaded ammunition and 
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contaminated by Pb shot pallets or their bits are usually concerned as the major source of 
Pb [23]. Other important sources of exposure are paint and ammunition dust contributing 
to the Pb load in house dust. Smoking also appears to the extra burden of Pb [24, 25]. Pb 
contaminated drinking water plays a very important role in human exposure [25]. 
Maternal distribution 
This metal is poorly absorbed through the skin but when it inhaled, the Pb containing 
particles take 24 hours to be absorbed [26] . Nevertheless, it has very low absorption 
ability through the intestinal tract (only 10% of ingested Pb) [27]. On the contrary, other 
researchers published reports on mitigating effects of dietary Fe, Zn, Ca and pre‐existing 
serum nutritional status, which have influence on the Pb accumulation and distribution. 
For example, the role of nutritional status in altering susceptibility to lead toxicity has 
been documented. Pb uptake increases when Fe- deficiency and/or low calcium intake 
occurs [27-29]. However, the positive correlation between maternal blood Pb and serum 
Zn levels have been observed [29]. Once Pb enters into the blood, it is distributed all 
organs but the particular organ of choice is bones, teeth (almost 94% of stored Pb in the 
body) because Pb can substitute for calcium (Ca). The half-life of Pb in the peripheral 
blood and soft tissue compartments is around one month, while in the skeleton it is 9-12 
years [30].  Most of the Pb (almost 70%) that enters the body, are excreted by the urine 
or through biliary clearance (ultimately, in the feces) [26] . 
Fetal transfer and health effects 
The transfer of maternal Pb either mainly through the placenta or later through the breast 
milk. Either prenatal exposure or breast milk could be the main source of an infant’s total 
Pb body burden. Contemporarily, a continuous decline has been observed in Pb’s 
concentration in humans [21]. Pb exposure from smoking may have a negative effect on 
the transplacental flow of micronutrients like glucose. Furthermore, it has an adverse 
influence on the growth and development of the fetus, and then on children [17, 18]. Pb 
can readily cross the placenta and can be reserved in fetal brains as early as the first 
trimester [31]. In another research, the authors indicate that maternal bone Pb burden is 
inversely related to birth weight [16, 32]. In addition, Pb can mobilize from maternal bone 
into plasma without detectable changes in whole blood Pb. These findings suggest that 
bone Pb remains in bone for years to decades, long after maternal external Pb exposure 
has declined [16]. Pb reaches the fetus by trans-placental transfer approximately at the 
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beginning of 12th to 14th week of pregnancy by passive diffusion that leads to deleterious 
effect afterward [12, 33]. Maternal Pb exposure during pregnancy at very low levels may 
adversely affect fetal bone growth. As Pb compete with Ca for deposition into bone due to 
similar chemical characteristics, it has a negative effect on child’s birth outcomes, 
particularly preterm birth [28]. In the paper about the relationship between the maternal 
blood Pb concentration and birth weight points out the significant negative impact of 
maternal blood Pb level on birth weight, even at concentrations < 5.0 μg/dL regarded as 
safe for children [34] 
1.3.3 Arsenic 
Sources 
Arsenic (As) is the most common metalloid that found on earth crust. It acquires 
characteristics of both a metal and a non-metal. The primary route of exposure is the 
regular diet, or by consumption of contaminated food or drinking water [35]. The highest 
concentrations of As have been found in seafood, followed by meats, cereals, vegetables, 
fruit, and dairy products. The non-toxic organic forms of As are mostly found in seafood, 
fruit, and vegetables, whereas toxic inorganic As forms are present in meat, poultry, dairy 
products, cereals and most importantly in drinking water. It is estimated that on average, 
approximately 25% of daily dietary As intake is in the form of inorganic species among 
the pregnant women in the Pacific Northwest, USA [36].  
Maternal distribution 
 It is believed that over a hundred million people worldwide are exposed to inorganic 
arsenic due to the exceed levels of As, recommended by the World Health Organization 
(WHO) which is 10 μg/L[37]. High exposures to inorganic As happen in the form of 
inhalation or through drinking water in regions of the world that is naturally 
contaminated with this element. Among the types of natural As, inorganic As is most 
prevalent. Inorganic As is metabolized in the body and produce methylarsonic acid 
(MMA) and dimethylarsinic acid (DMA) which are less toxic and readily excreted in urine 
while reduced forms of the methylated metabolites, are highly toxic and may be 
responsible for part of the arsenic toxicity [38]. The half-life of inorganic arsenic is 4-6 
hours (h) which is quite long for methylated metabolites (20-30 h)[59]. The methylation 
of arsenic is influenced by dose level, age, and gender [39].  
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Fetal transfer and health effects 
Adverse effects of As contamination include unfavorable reproductive/developmental 
issues like SGA, pre term birth, growth retardation of fetus etc. [40, 41]. As, which is a 
potential toxicant, can be correlated with adverse birth outcomes (birth weight, birth 
length, head and chest circumferences) due to prolong maternal exposure during 
pregnancy[19]. As can readily cross the placental barrier by glucose transporter 1 (Glut1), 
which has been shown to catalyze the cellular uptake of both arsenite and its methylated 
metabolite (like MMA, DMA). After As crosses the placental barrier, it accumulates in the 
placenta. Subsequently, it produces toxins in placental tissues which are mediated via 
oxidative stress. These toxin elements interfere with nutrient transport to the fetus and 
thereby affect fetal growth [41]. Another acceptable explanation is epigenetic alterations. 
Prenatal arsenic exposure has been associated with deregulation of microRNA expression 
profiles in umbilical cord blood, and DNA methylation status in maternal and umbilical 
cord blood. MicroRNAs have an important role in normal placental development; and 
alteration of microRNA expression profiles have been associated with abnormal 
placentation and SGA births [42, 43].  In addition, maternal arsenic exposure via drinking 
water is associated with fetal loss, small size at birth, infant morbidity and mortality [37]. 
Conversely, in one publication the author reported negative associations between arsenic 
exposure and birth weight, birth length and gestational age [44]. 
1.3.4 Mercury 
Sources 
Mercury (Hg) is an accumulative neurotoxin that exists in the surrounding by natural and 
anthropogenic sources. These sources include volcanoes, forest fires, fossil fuels such as 
coal, human activities such as mining, petroleum or discharge from hydroelectric plants, 
and paper industries contribute to a certain level in the environment[45]. Elemental Hg, 
transformed into methylmercury by bacteria, exists in lakes and rivers. Methylmercury 
(MeHg) has the ability to bio-accumulate in aquatic and terrestrial food chains. It is 
established for the main route of human exposure. So, intake of fish which are long-lived 
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Maternal distribution 
At room temperature, Hg is a liquid that is volatile, toxic in both its elemental (Hg°) and 
ionized forms. Elemental Hg is less capable of absorbing from the gastrointestinal tract 
(less than 0.1%), although 7% and 95% of inorganic and MeHg are absorbed 
correspondingly [47]. The Hg gas, which is well absorbed in the lung and easily crosses 
cell membranes, inhaled vapor dissolved in tissue fluids and the bloodstream moves 
rapidly throughout the body. Afterwards, it readily crosses the blood–brain and placental 
barriers and sits there. MeHg, which usually ingested, is absorbed into the bloodstream. 
Then the organ of choice is brain, liver, kidney, hair, biliary tract for distribution. From 
blood compartment to all the body tissues the process takes about 30 to 40 hours. On 
average about 5% of the absorbed dose remains in the blood compartment. Hair Hg levels 
closely follow blood levels. However, in the time of execration, different forms take 
different pathways. MeHg is excreted through feces, while inorganic Hg through urine 
with a half-life of 45-70 days [48] .  
Fetal transfer and health effects 
MeHg is instantly ready to cross placenta so that fetal level have been found greater than 
maternal levels [49]. Actually, the MeHg binds to the neutral amino acid carriers (such as 
cysteine). As a result, the fetal side of the placenta has reduced affinity and leads to one-
way placental transfer [50]. A study about GSTM1/GSTT1 polymorphism and blood 
mercury published in 2010 suggested that interactions of Hg with glutathione S-
transferase (GST) play a role in reducing birth weight. This study found that both 
umbilical cord blood Hg and maternal blood Hg were inversely related to birth weight. 
Further, they specifically examined the significant association between GST 
polymorphisms in mothers blood Hg and infant birth weight [51]. Another study in 
Norway called Norwegian Mother and Child Cohort Study (MoBa), investigates the 
potential association between birth weight and estimated Hg intake based on dietary 
information from an FFQ. This MoBa study revealed that women with high Hg exposure 
delivered offspring with reduced birth weight [52]. On the other hand, a cohort study 
named Birth Cohort 1 in the Faroe Islands was established to investigate the effects of 
fetal exposure Hg owing to the frequent consumption of whale meat during pregnancy. 
Follow-ups of the children in this cohort have indicated the serious and permanent 
neurobehavioral effects of fetal exposure to Hg even at low levels. These are the most 
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important findings of the present assessment [20]. However, some researchers claim no 
associations with birth weight and Hg [53]. Counter wise, positive associations are 
reported in populations with high fish consumptions, suggested as a protective effect of 
fish and selenium in it. [54].  
1.3.5 Cadmium  
 
Sources 
Cadmium (Cd) is naturally occurring toxicant found in the earth crust. Main sources for 
exposure are industrialized release include mining and smelting of Zn, battery 
manufacturing, pigment production for paints, and in tobacco products [8]. Further, Cd is 
one of the most important toxicants related to pregnancy outcome largely depend on 
smoking [55, 56]. For nonsmoker, the main source for Cd is food like cereals, potatoes, 
and vegetables which grow in soil that is naturally rich in Cd or even from the use of Cd-
containing fertilizers and pesticides [57, 58]. Food grows in contaminated soil like wheat, 
rice, vegetables contain a greater amount of Cd. Other studies also revealed that Cd from 
the soil was absorbed and retained in rice to a great extent. Further, Cd in rice has been 
exclusively correlated with Cd body burden [57, 59].  
Maternal distribution 
Cd can be absorbed via inhalation and ingestion. Absorption is enhanced by dietary 
deficiencies of Ca and Fe and by low protein diets. Low dietary Ca stimulates synthesis of 
Ca-binding protein, which enhances Cd absorption. However, human take most of the Cd 
via cigarette smoking. Through smoking, nearly 10-30% of the Cd content of a cigarette is 
inhaled. Further, absorption of Cd through the lungs is more effective than through the 
gut [61]. In blood, Cd can be bound with red blood cells and high-molecular-weight 
proteins in plasma. The Cd bound protein, metallothionein, portrays most recent 
exposure with a half-life of 40-90 days while Cd stored in kidney and liver has a half-life 
of 10 years or more [60, 61].  
Fetal transfer and health effects 
Cd exposure influences the hormonal release of the pituitary hormones, which play an 
essential role in reproductive health, fetal growth, and development [58]. Gender 
differences in susceptibility at lower exposure are uncertain, but recent data indicate that 
Cd has estrogenic effects and affect female offspring [62]. Another study establish that Cd 
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concentration in the placenta was inversely associated with birth weight [58]. Cd can 
express placental gene 11β-HSD2 which is responsible for the transfer of glucocorticoid 
through the placenta. Consequently, fetal growth retardation may occur [62]. Cd also acts 
as a competitor with Zn which is essential for fetal growth and development as it is being 
delivered to the fetus. The proposed mechanism behind a Cd–Zn interaction is the 
accumulation of Cd in placenta that stimulates the synthesis of the metal binding protein 
metallothionein (MT).  Furthermore, Cd bound MT can cause Zn retention in the placenta 
with subsequent reduced Zn transfer to the fetus[63]. Some studies reveal that maternal 
smoking is related to decrease birth weight in comparison to the nonsmoking group. 
Moreover, mothers who smoke >20 cigarettes/day have high risk to deliver low birth 
weight, small for gestational age and pre-term babies due to Cd effect [55, 64]. 
Furthermore, maternal smoking during the third trimester is the strongest predictor of 
birth weight after adjusting for gestational age. Research about maternal smoking and its 
association with birth weight shows that each cigarette smoked per day during the third 
trimester contribute to a 27-g reduction in the birth weight of the infant [56]. A study on 
heavily Cd polluted area in Myanmar revealed that a higher maternal Cd concentration 
increased the likelihood of a low birth weight but not preterm delivery [4]. 
1.3.6 Development of Pregnancy and placental transfer of toxic elements 
Critical period of exposure  
A critical age period can be defined as one in which an exposure must occur to influence 
a later outcome, while a sensitive period is one in which an exposure has a larger effect 
than the same exposure during other periods, and these critical age period can be i.e. 
preconception, pregnancy, infancy and childhood [10, 65, 66]. In this context, our 
particular concern is the pregnancy period. 
1.3.6.1 Development of pregnancy: 
 
Pregnancy is an unusual physiological condition for the female body. During the period of 
pregnancy, not only the growth of fetus occurs but also tremendous physiological changes 
for mother happened along with preparation for lactation. These changes include 
enlargement of mothers’ uterus (can be enlarged 5 times of its initial size), changes in 
plasma volume and erythrocyte, as well as increase in whole blood volume. In cardio 
vascular systems, it is changed by increasing cardiac output. Besides, renal plasma flow 
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and glomerular filtration rate (GFR) both increase due to renal vasodilatation, and 
importantly plasma volume increases progressively throughout normal pregnancy[10]. 
Most of this 50% increase occurs by 34 weeks of gestation and is proportional to the birth 
weight of the baby.  
Placenta is developed at the time of implantation in the uterine cavity. This occurs around 
6 to 7 days after conception and continues throughout the pregnancy with a simultaneous 
increase in uteroplacental blood flow (up to 40-fold during the course of the pregnancy) 
[67]. The placenta plays a vital role to keep the fetus connect with the mother via the 
umbilical cord. The main function of the placenta is providing oxygen and nutrients to the 
growing fetus and removing waste products from fetal blood [68]. 
In the first trimester, placental growth is more rapid than the fetus growth. The placental 
weight is almost same to the fetus around 17 weeks of the conception and approximately 
one- sixth of it at term[69]. Alongside, maternal placental blood flow continues to increase 
throughout pregnancy, which is considered to reflect vasodilation [10, 67]. For some 
particular compounds, the placenta functions as a barrier and thereby protects against 
the infections from the mother to the fetus and for other substance, it can accelerate their 
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Figure 1: Mechanism of drug transfer across the fetus after maternal drug administration. 
(Reprinted with permission from Syme et al., 2004). 
 
1.3.6.2 Placental transfer of toxic elements 
 
It is logical to presume a change in levels of different elements during the period of 
gestation and after delivery because of the expansion in plasma and red blood cells. 
Though, some studies also suggest that RBCs are better than plasma at reflecting the 
trans-placental transfer of Pb and Hg from the mother to the fetus [70]. Moreover, the 
study shows the result for cord/maternal ratios in RBCs that strongly suggest Pb, Hg, and 
Cd exhibit free trans-placental passage from mother to fetus. However, the result they 
showed for Cord/maternal ratios in plasma is varied from the result from RBCs. The result 
for plasma ratio is less reflective than the RBC ratio [71]. So, it is notable that these 
elements have a strong association with RBCs.  
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However, unfortunately, a few toxic elements (for example, Pb, Hg, Cd, As etc.) are 
permissible to the placental barrier. Elements with a molecular weight below 500 are 
readily transferred across the placenta [27]. Many researchers evaluate metal exposures 
and consequential maternal fetal health risk by using human placenta [28]. The toxic 
elements Pb, Hg, As and Cd are the most common toxicants, which are well-known to cross 
the placenta and to accumulate in fetal tissue. These chemical compounds can cross the 
placenta by various mechanisms [71]. Maternofetal and fetal-maternal diffusional 
transfer depend on the thickness of the dividing layers and different stages of pregnancy. 
During early pregnancy, the maternal-fetal diffusion distance is in the range of 20–38 mm, 
while at the end of pregnancy, the minimal diffusion distance is about 4 mm. In contrast, 
facilitated and active as well as vesicular transports are influenced by the number of 
layers of the placental barrier [49, 71]. Toxicokinetic of Pb, Hg, and Cd is very distinctive 
in the placenta. Pb is entered by passive diffusion into placenta cells [31]. Meanwhile, 
accidental exposures of Hg in pregnant women show that the placenta cannot prevent the 
passage of Hg without exception of any chemical form. The chemical form of Hg 
determines its cellular uptake. Both Hg vapor (assumed to be transported by passive 
diffusion) and MeHg (transported by amino acid carriers) can easily pass the placenta [49, 
50]. On the other hand, inorganic Hg is more likely to be trapped in placenta tissues [51]. 
The placental passage of Cd is limited suggesting a partial barrier for this element. The 
divalent metal transporter 1 (DMT1), is known to mediate intestinal uptake of Pb and Cd, 
might also play a crucial role in placental uptake of Pb and Cd [72]. The major function of 
DMT1 is Pb uptake. This transporter is abundantly expressed in human placenta 
throughout gestation [73]. 
Figure 1 shows different types of pharmacokinetics including transplacental transport 
and metabolism that determine the extent of maternal to fetal drug transfer and fetal drug 
exposure. The size of the arrows approximates relative importance, although this is drug-
dependent and will vary during pregnancy with fetal and placental maturation [12]. The 
fetus is particularly vulnerable to the effects of heavy metals because of the high rate of 
cell division and differentiation. Therefore, relatively low levels of exposure that do not 
harm the mother may have a reflective effect on the growth and development of the fetus 
and development during childhood [5]. Cd, one of important toxic elements that can pass 
through placental barrier, causes some indirect health effect such as changes in placental 
hormone production and transplacental nutrient passage of essential trace elements. 
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These effects may exert a far-reaching impact on human pregnancy and immune 
processes related to the function of the maternal-fetal interface [63, 74]. In addition, 
moderate level of prenatal exposure of Cd may have a detrimental effect on birth 
outcomes [75]. Pb, another toxic element, readily crosses the placenta and sits in fetal 
brain in the first trimester, and which is a concern for the later life. Low-level Pb exposure 
in children does not cause overt clinical symptoms but has permanent effects on 
cognition, behavior and school performance [76].  Some other studies also revealed that 
both Cd and Pb in placenta were negatively correlated with birth weight, head 
circumference and placental weight [13, 14]. On the other hand, the relationship between 
arsenic (iAs) contamination through water and low birth weight, and intrauterine growth 
retardation is established [19, 35, 40]. In this study, we analyzed birth outcomes 
especially, low birth weight and measurement of toxic elements in maternal blood during 
3rd trimester and 3 postpartum days to establish the alteration in the level of toxic 
elements in different time period. 
1.3.7 Birth weight and influential factors 
 
Birth weight can be defined as body weight just after birth. During pregnancy, babies live 
in amniotic fluid, and after birth they lose a fraction of their birth weight. According to 
WHO, children above 2.5 kg are considered as normal birth weight [77] . Low birth weight 
(LBW) neonates are vulnerable for risk of mortality and morbidity. However, newborns 
who have a birth weight above 4500 grams considered as macrosomia or high birth 
weight [78]. Low birth weight (LBW) is a major public health concern for both developed 
and developing countries, and one of the most frequent causes for child morbidity and 
mortality in recent years [2, 79]. According to WHO, more than 20 million infants worldwide 
representing 15.5 percent of all births, are born with low birth weight, and 95.6 percent of them 
are from developing countries [80]. Usually, it describes if fetus weighted 10% less with 
respect to gestational age called small for gestational age (IUGR) [3].  
Infant birth weight is a strong predictor for recent health status. In general, the lower the 
birth weight is the higher the risk of infant mortality [81]. Another factor is that, on a 
population level, mean birth weight is associated with infant mortality. Groups with lower 
mean birth weight often have higher infant mortality (e.g. the infants of mothers who 
smoke, or of mothers with lower socioeconomic status) [79]. Finally, birth weight is 
associated with health outcomes and development later in life. Asthma, low IQ, and 
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hypertension have all been reported to be more common among those who were small at 
birth [3, 82].  
Newborn baby’s weight can vary greatly; it can depend on mother’s own health and 
nutrition during pregnancy, as well as their inbuilt genetic make-up, which comes from 
both parents [66, 79]. Although smoking, alcohol habits, maternal weight, and pre-
pregnancy height are the important determinants for low birth weight [17]. Maternal 
active smoking during pregnancy induces birth-weight decrease and significantly 
increases the risk of LBW. Reduced birth weight was found to be adversely correlated 
with the extent of maternal smoking during pregnancy. One of the authors revealed that 
maternal smoking of ≥20 cigarettes/day is significantly associated with LBW, small for 
gestational age (SGA), and preterm birth [64]. The effect of nicotine (found in cigarette 
smoking) is stimulating maternal catecholamine release. As a result, uterine 
vasoconstriction occurs. Maternal smoking increases carboxyhemoglobin levels of 
umbilical arteries and results in fetal hypoxia [18]. Maternal gestational weight gain is 
one of the most important determinants and has an association with low birth weight 
compared to those who gain weight within the limit of the American Institute of Medicine 
guidelines [83]. Many other factors like malnutrition, stress, use of illicit drugs, toxic 
substance exposure during pregnancy, cesarean delivery, maternal age, prenatal medical 
visits, obesity, gestational diabetes, eclampsia, and parity also play an important role on 
determining newborn’s birth weight [17]. Moreover, in some studies it reveals that female 
gender is associated with LBW. The reason for association of LBW with the female infant 
is biological and inherent and also non-modifiable [1].  Prolonged exposure of toxic 
elements even at a low-level during pregnancy may adversely affect some childbirth 
outcomes such as low birth weight. Pre-natal exposure of Pb, associated with reducing 
fetal birth weight, or ponderal index is established specifically for girls [32, 84]. Besides, 
many studies have established that the relation of maternal blood Cd level has significant 
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2 Material and methods 
 
2.1 MISA study 
The Northern Norway Mother-and-Child Contaminant Cohort Study [in Norwegian: 
Miljøgifter i svangerskapet og i ammeperioden (the MISA study)] was initiated in 2007 
with the goal to measure concentrations of environmental contaminants in expecting 
mothers (and in their newborn babies) who lived in the three most northern counties of 
Norway, namely Nordland, Troms and Finnmark. The primary objective was to study the 
exposure through food intake, as well as examining the influence of maternal 
anthropometric and 24 socioeconomic factors. The MISA database is considered suitable 
for exploring associations between contaminant exposure and diet, enhancing 
understanding of the relationship between physiological changes that occur in mothers 
and contaminant activity through the body till its fate (including transfer to the infant 
before and after birth), and conducting prospective health studies of the children[21, 87].                                            
2.2  Geographical description and recruitments  
The recruitments for the MISA study took place from May 2007 until December 2009 in 
different counties of northern Norway. Nordland, Troms and Finnmark as described in 
Figure 2. Pregnant women in the selected study area were invited by a written invitation 
administered by ultrasound clinics personnel or midwife consultations in selected region. 
The participating delivery departments were: Nordland Hospital (Bødo and Lofoten), 
University Hospital of North Norway Trust (Tromsø and the labour wards of North-Troms 
(Nordreisa) and Mid-Troms (Lenvik)), and Finnmark Hospital (Kirkenes, Hammerfest 
and the labour ward of Alta), municipality of Karasjok and Kautokeino in Finnmark [21].  
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1: Rod Wolstenholm, UiT, Adapted from Veyhe 2016 
 
      
Figure 2: Map of MISA study area1  
  
 
The MISA study adopted a cohort study design. It had three different sampling points, for 
instance, P1 –before week 20 in the 2nd trimester, P2 – at the 3 days postpartum and P3 
– 6 weeks postpartum but here P1 and P2 sample is our particular concern. Further, in 
our study we are going to use P1 for 2nd trimester and P2 for 3 days postpartum. A total 
of 2600 woman were invited to participate, 609 responded of whom 52 avoided further 
contact. The remaining 557 participants received the project package containing a 
questionnaire and biological sampling kit. Among 557 participants, 15 did not give blood 
sample and 27 did not hand in consent form, thereby 515 women were left eligible for 
study, 461 of these presented at delivery, 395 provided blood sample and 382 provided 
whole blood sample at each of three points. All whole blood specimen sample collected 
till end of January 2009 were selected for analysis, and the concentration for essential and 
toxic elements in a subset of 282 respective donors constituted our primary the study 
group (see Figure 3). This decision was necessitated by laboratory constrain.  
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For this study, among the 282 participants we excluded 20 women as they did not meet 
certain criteria and might have influence on birth weight [88]. Finally, we include 262 
women for the study. Among the 20 excluded participants 2 were diabetic (one was type 
1 diabetics and another gestational diabetics), 7 pre-eclampsia, 2 hypertensives, 6 twins, 
3 had baby with congenital abnormality. The relation between gestational diabetics and 
increased birth weight (macrosomia) is recognized  [17]. Many others factor rather than 
diabetics also have impact on birth weight, in particular maternal hypertension, pre-





Figure 3: Study population and participants in this study (Adapted from Hansen 2011) 
P1, 2nd trimester around 18 gestational weeks; P2, 3 days postpartum 
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2.3 Enrollment and Data Collection 
In the MISA study, the participants completed a detailed self-reported information 
questionnaire (Appendix 1) relating to personal characteristics, obstetric history, diet and 
life style. In addition, at all blood sampling points a simple questionnaire (Appendix 2) 
was administered to obtain personal information about current diet, smoking and alcohol 
habits, medication and dietary supplements. Maternal weight was measured at each 
period, and self-reported pre-pregnancy weight and height (verified against that in the 
medical record) were attained from pregnant women. During assessment of body weight 
a standard weight machine was used while wearing light clothes and without shoes 
(rounded to the nearest kilo)[90]. Maternal characteristics like age, smoking status, civil 
status, medical status and obstetrical data like parity, gestational age, newborn medical 
status, birth weight, length and head circumference, obtain from Medical Birth Registry 
of Norway (MBRN)[91].  
2.4 Blood Sampling and chemical analysis 
The maternal whole blood samples considered in this study were drawn by venous 
puncture at all three sampling periods (P1, P2 and P3). However, in this experiment, we 
consider elements analyzed from (P1) and (P2) periods. Samples of maternal whole blood 
for three collection periods were analyzed for levels of Pb, As, Hg and Cd. Chemical 
analysis was done by using the inductively plasma- mass spectrometry (ICS-MS) 
technique, employing a high-resolution magnetic sector field Element 2 mass 
spectrometer (Thermo Electron, Bremen, Germany) calibrated with whole blood matched 
standard solution [21, 88].  Analyses for Toxic elements were done by the National 
Institute for Occupational Health (NIOH), Oslo, Norway[88].  
2.5 Description of variables   
 
Mothers age was obtained at delivery, have been reported both as on a ratio scale and as 
grouped categories (<19, 20-24, 25-29, 30-34, 35-39, >40).  Number of years in school 
were treated both on a ratio scale and categorized into grouped according to Norwegian 
education system (Primary school <10 years, Secondary school 11-13 years, Higher 
education >14 years). Household income was measured in yearly income (NOK). Parity 
was based on deliveries occur after 12 weeks of pregnancy and reported as ratio scale 
(range 0-4). Gestational age was calculated on basis of ultrasound and were treated as 
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interval variable (days). Mother’s self-reported height (cm) and weight (kg) in 2nd 
trimester was treated on a ratio scale. Pre-pregnancy BMI was calculated by pre-
pregnancy weight in kg/ height in m2[92]. Data about smoking (before pregnancy, during 
pregnancy and third post-partum days; yes or no) was self-reported regarding smoking 
or not, or frequencies of smoking. If missing data on maternal smoking habit, we 
compared the data from MISA and MBRN and made new variables. Alcohol consumption 
was treated as teetotaler (yes or not). Daily total energy intake in Kilojoule (KJ) were 
based on self-reported dietary intake [21].  
2.6 Statistical analysis 
All statistical analysis was carried out by using the IBM SPSS Statistic for Mac (version 
25.0, SPSS Inc., Chicago, IL, USA). Descriptive statistic was run to summarized the data of 
the study group and were presented as number or percentage, mean, median and 
minimum to maximum range and standard deviation (SD). One-way ANOVA used for 
compare birth outcome differences between boys and girls. Chi square test was used to 
test differences between categorical data like smoking status between gender. Normality 
and deviations of outcome variables and elements were assessed from histograms and 
Kolmogorov-Smirnov (KS) tests. Birth weight was normally distributed. 
The distribution of maternal concentration of toxic elements were found not normally 
distributed, so the compounds were Log transform (base 10 logarithm, log10x). Paired 
sample t-test was done to explore the change in concentrations between 2nd trimesters 
and 3 days postpartum. To account for the dependency between repeated measurements 
collected for each participant across time, p-value is reported.  
Relationships between concentration of toxic elements and birth weight were visualized 
by scatter plots. Pearson correlation coefficients (R) were calculated for linear 
relationship. Simple linear regression was employed to detect association between birth 
weight with related independent variables included toxic elements. Predictors (p-value 
0<.25) from univariate regression were included to build multiple regression model 
aimed to observe relationship between birth weight and elements adjusted for different 
characteristic. The independent variables tested by using the enter method regression 
approach included maternal age, pre-pregnancy body weight, height, parity, gestational 
age, gender of the baby, and log toxic elements. Six different models were built for the 
toxic elements, with and without co-existing elements, and including covariates obtained 
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an overall p-value below 0.1. Models using both 2nd trimester and 3 days postpartum 
concentrations of elements were tested out to find the best models. The models were both 
overall and stratified on gender. Unstandardized beta coefficient (ß), confidence intervals 
(95% Cl) and p-value explained the relationship and the boundaries of the interval. F-test, 
R2 and overall p-value for total model were reported to observed variability and extent 
to accuracy of the model. p-values< 0.05 were considered as significant. 
2.7 Ethical considerations  
The MISA study was approved by the Regional Committees for Medical Research Ethics 
and the Norwegian Data Inspectorate (Appendix 3). Participation of the women were 
voluntary, and the women signed an informed consent form (Appendix 4) [88]. 
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3 Result and Analysis 
3.1 Sample characteristic 
Particular characteristics of 262 participating pregnant women are presented in Table 1. 
The study found that most of the women, 45.4%, were from Troms county, 33.2% from 
Nordland and rest of them (21.4%) were from Finnmark. The maternal mean age was 
31.2 years and ranging from 18 to 43 years. The percentage for nulliparous and para 1 is 
nearly equal (39.3% and 39.7%, respectively). Majority of women delivered at term with 
mean gestational age 39.6 weeks. Almost 60% of the respondents’ annual household 
income was equal or more than 600 000 Norwegian kroner while 38.7% had less than 
600 000 Norwegian kroner. Majority of the respondents were cohabited (60.7%) 
followed by married (34.4%) and single (4.6%).  The literacy rate of the mothers was 
relatively high, among them 76.5% and 21.6% had higher education more than 14 years 
and secondary school education while only 2% were under 10 years of education. 
Precisely half the study population were within a normal BMI range (BMI 18.6-24.9 
kg/m2) while 33.7% were overweight (BMI range 25-29.9) and rest of 15.9% and .4% 
represent extreme groups (obese and underweight groups). Among the participants, 
17.1% had smoking habit in beginning of the pregnancy while only 6.5% smoked at the 
end of the pregnancy. Moreover, 23% respondents also reported that they were smoked 
at least 6 months before pregnancy. High frequency of smoking was observed among the 
mothers carrying baby boys (22.5%) than girls (11.6%) (p-value=0.020). Respectively, 
only 7% respondent reported about no alcohol use as they were a teetotaler. In dietary 
portion women reported mean energy or calorie intake was 7873 KJ/day while the range 


















Page 23 of 51  
Table 1: Characteristics of the study cohort      
Mean (SD) or n (%) Median Min-max 
County of living at Inclusion (n=262)    
Troms                                                                            119 (45.4)   
Nordland 87 (33.2)   
Finnmark 56 (21.4)   
Maternal age (years) at Delivery (n=262) 31.2 (4.8) 31.7 18-43 
Age groups: in years    
<19 3 (1.1)   
20-24 27 (10.3)   
25-29 70 (26.7)   
30-34 102 (38.9)   
35-39 50 (19.1)   
40+ 10 (3.8) 
 Household income, annual (n=245)b    
>600 000 NOK 
 
147(60)   
Education (years of school) (n=255) 15.6 (2.7) 16 9-22 
Educational years in groups    
Primary school, <10 n (2)   
Secondary school, 11-13 n (21.6)   
Higher education, >14 n (76.5)   
Parity, all live births (n=262) 1.8 (.302) 1 0-4 
Para 0 103 (39.3)   
Para 1 104 (39.7)   
Para 2 39 (14.9)   
Para 3 12 (4.6)   
Para 4 4 (1.5)   
Gestetional age (weeks) (n=262)c 39.6 (1.4) 40 30-42 
<37 weeks  14 (5.7)   
Body weight of mother at 2nd trimester (kg)a 71.84 70 40-120 
Height of the mother (cm)a 166.7 167 145-183 
cPre-pregnancy BMI (n=262): (kg/m²) 31.2(4.8) 31.7 18.35-43.71 
cPre-pregnancy BMI in groups: (kg/m²)    
Under weight, <18.5 1 (.4)   
Healthy,18.6-24.9 126 (50)   
Overweight,25-29.9 85 (33.7)   
Obese,>30 40 (15.9)   
Smoking Habits (yes or regularly)d    
smoking at last 6 months of pregnancy (n=256) 59 (23)   
smoking at the beginning of pregnancy (n=258) 44 (17.1)   
smoking at the end and after delivery(n=248) 16 (6.5)   
Alcohol Intake     
Teetotaler (n=258) 15 (6)   
Total energy Intake, KJ (n=257) e 7973 (1993) 7891 3135-12857 
 
aMaternal body weight, height was taken at 18.2 weeks; bIncome based on annual household income. 
cGestetional age detect by ultrasound; dSmoking status is yes/no through 2nd trimester of pregnancy. 
eIn total energy intake data 2 missing data and 3 extreme outliers indicating over-reporting were removed from data 
 
3.2 Pregnancy outcomes 
 
 
Table 2 shows the major pregnancy outcomes among the north Norwegian newborn’s 
characteristics overall and according to gender.  In all 50.4% of the newborns were boys. 
The overall mean birth weight including both genders was 3653 gm. However, boys 
appear almost 200 g bit heavier than girls. The overall mean length of the newborns was 
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50.3 cm and with girls 0.5 cm shorter than boys. Likewise, for head circumference with 
overall 35.6 cm, girls show 0.6 cm lower circumference compare to boys. There were 




Table 2: Primary fetal outcomes among North Norwegian Mothers in the MISA study (2007-2011) 
  Overall Boy Girl p-valuea            
 Gender (n=262) 
 Babies birth weight:  
 
 
50.4 49.6        <0.001 
 mean 3653 3738     3565 0.006 
 min- max 1720-5170 1720-4930 2390-5170  
 std. Deviation 509.96 541.39 461.83  
Babies birth length:     
 mean 50.39 50.91 49.84    <0.001 
 min- max 41-57 41-57 45-56  
 std. Deviation 2.14 2.29 1.8  
Babies head circumference:     
 mean 35.64 35.93 35.35   0.002 
 min- max 27-40 27-40 32-39  
 std. Deviation 1.49 1.5 1.5  
aFor gender comparison, ANOVA test was used 
 
 
3.3 Detection of frequencies, normality and outliers of toxic 
elements 
 
The detection for frequencies for toxic elements were 100% except Hg at P1 (99.1%) and 
As at P1 (98.6%). Regarding log transformation of every elements, the frequency 
distributions explore by histogram and detected by test for normality (KS test) were not 
normally distributed except for Hg at P1 and CD at P2 for smokers. However, the 
histograms were satisfied. A small number of extreme outliers by using boxplot observed 
for Cd (2 in both P1 and P2) and Pb (1 at P1) and were keep in dataset during 
measurement of the concentration. As they not were appraised to represent unusually 
high concentrations, they were also included during regression analysis.   
3.4 Maternal concentrations of toxic elements 
 
The maternal concentration and ranges for the selected toxic elements are reported in 
table 3. Pb had the highest concentration followed by As > Hg > Cd(smoker) > 
Cd(nonsmoker) at the point of both P1 and P2. This sequence shows that nearby all the 
elements (except of Hg), Pb concentration rise at point P2 and smoking has impact on 
blood Cd levels. Employing the paired sample t-test for log transformed concentrations, 
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all trends across the 2-different time period were significant (p-value < 0.001). All the 
elements tend to P2 > P1 pattern except Hg which follow P2 < P1.  
 
Table 3: Maternal Whole blood concentrations of toxic elements during 2nd trimester in pregnancy and 
3rd days of postpartum-The MISA study (2007-2011)  
2nd Trimester (P1) 
  
3rd day of postparturm (P2) 
 
 Concentration (𝝻g/L)   Concentration (𝝻g/L)  
Compounda n AM SD GM Min-Max n AM SD GM Min-Max p-valueb 
As 262 2.1 2.11 1.47 0.14-12.77 262 2.4 2.36 1.74 0.14-17.1 <.001 
Cd(smoker)c 44 0.52 0.51 0.36 0.08-2.74 16 0.72 0.53 0.56 0.13-2.42 <.001 
Cd(non-smoker) 214 0.17 0.08 0.15 0.04-.72 232 0.19 0.08 0.17 0.05-0.54 <.001 
Hg 262 1.5 1.01 1.21 0.10-6.64 262 1.24 0.72 1.05 0.2-5.5 <.001 
Pb 262 8.1 3.84 7.5 2.22-41.09 262 9.4 3.8 8.8 3.6-28.13 <.001 
aAs, arsenic; Cd, cadmium; Hg, mercury; Pb, lead; n, number of participants, GM, geometric mean based on ((𝑙𝑜𝑔10
𝑥 ); AM, 
Arithmetic mean; min, minimum; max, maximum. 
bAnalysis for GM values was by the paired sample t test; c for the smoking variable in P1 4 data and in P2 14 data was missing. 
 
3.5 Predictors in the linear models 
3.5.1  Simple linear regression 
In the simple linear regression, no elements were significant related to birth weight. 
Further according to standardized beta (𝛽 standard) with limited contribution. However, 
both Pb at P1 and P2 met the criteria of a p-value below 0.25 (p-value = 0.190 and p-
value= 0.198, respectively, table 4). Scatter plots were also used to illustrate the 
relationships between the concentration of peaking Pb at P2 and birth weight. According 
to the plot (Figure 4) the correlation was low and non-significant. Along with log 
transformed elements, potential confounders were also included in the simple linear 
regression model on the basis of rational associations in previous studies [4, 44]. In simple 
linear regression model, there were significant (p-value < 0.05) association with birth 
weight and mother’s age, parity, gestational age, mother’s height, pre-pregnancy weight, 
BMI of the mother, gender of baby and Pb at both P1 and P2 (Table 4). Mother’s age one 
of most significant and relevant positive factor for determining child’s birth weight. (p-
value = 0.010). It means increasing mother’s age by one year 16.5 gm increasing the birth 
weight. Parity, mother’s height and gestational age are constituted as a positive predictor 
for birth weight (p-value < 0.001).  By switching from girls to boys tends reduce birth 
weight (p-value = 0.006). Maternal pre-pregnancy smoking habits show no association 
with birth weight.  No association between birth weight and education, household income, 
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Table 4: univariate linear regression of birth weight adjusting for different covariates. Weight Changes gram/unit (95%cl) and P-
value   
2nd trimester 3rd days postpartum  
     (P1)  
 
     (P2)  
 
aß b95% Cl cR² d𝛽 
standard 





16.53 3.98 to 29.09 0.025 .159 0.010      
Education 
(years) 
1.98 −20.9 to 24.9 0.0001 0.01 0.865      
Income >600 
000 kr 
7.71 −39.5 to 54.9 0.0004 0.02 0.748      
Parity (0-
multipara) 
124.61 58.94 to 190.24 0.051 0.23 <0.001      
Gestetional age 
(in days) 
24.44 19.11 to 29.78 0.24 0.49 <0.001      
Mother's Body 
weight  
10.56 6 to 15.13 0.074 .273 <0.001      
Mother's height 
(cm) 
14.56 5.3 to 23.78 0.04 0.19 0.002      
BMI of mother 
kg/m²) 
22.78 9.07 to 36.49 0.04 0.19 0.001      
Gender of baby 
(boy/girl) 
−173.28 −295.8 to −50.8 0.029 −0.17 0.006      
Alcohol 147.7 −94.7 to 390.1 0.006 0.07 0.231      
Smoking 
(yes/no) 
−21.1 −187.6 to 145.3 0.0002 −0.01 0.803      
Cadmium log, 
𝝻g/L 
−76.8 −302.3 to 148.6 0.002 −0.04 0.530 −153.31 
−429.36 to 
122.73 
0.005 −.068 0.275 
Arsenic log, 
𝝻g/L 
19.8 −152.8 to 192.5 0.001 0.01 0.821 −40.8 
−210 to 
128.4 
0.001 −.029 0.635 
Lead log, 𝝻g/L −237.62 −595.9 to 120.64 0.007 −0.08 0.190 −250.02 
−631.4 to 
131.33 
0.006 −0.08 0.198 
Marcury log, 
𝝻g/L 
81.6 −123.2 to 186.5 0.002 .049 0.433 −40.1 
−283 to 
202.9 
0.0004 −0.02 0.740 
Maternal body weight, height and blood sampling were taken at 18.2 weeks 
Income based on annual household income. 
All the metals are log transformed ((𝑙𝑜𝑔10
𝑥 ) And taken at 2nd trimester (P1) and 3rd postpartum day (P2) time point.   
Gestetional age detect by ultrasound. 
Smoking status is yes/no through 2nd trimester of pregnancy. 
Alcohol based on drinking habit(teetotaller) through their whole life 
aß Unstandradized beta, b95% Cl Confident interval, cR2 pearson coralation, d𝛽 Standardized coefficient 
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Figure 4: Scatter plot of log Pb 3 days postpartum (P2) versus birth weight of the baby 
grouped by gender (Pearson’s r = 0.080) 
3.5.2 Multiple linear regression 
 
The regression model included all log toxic elements, variables with p-value < 0.25 
revealed in the simple regression analyses. Due to inter-relation between BMI and height 
and weight, BMI were excluded from further testing. Age was also excluded in the final 
overall and stratified multivariable models due to p-value > 0.1. For some models (Pb and 
Cd separately) we also adjust for smoking due to its relation with the elements [56, 93].   
Concentrations of toxic elements from both 2nd trimester and 3 days postpartum were 
tested. However, we choose to present the best model; all representing the highest 
maternal concentrations of the toxic elements, namely Pb, As and Hg at P2, and Hg at P1. 
Thus, data representing the lowest concentrations are not been presented. 
The multiple regression model 1 (table 5) was run by all four toxic elements adjusted for 
the different covariates in both overall and gender stratified models. Moreover, this model 
suggested a negative association of the toxic element Pb at P2 with birth weight in baby 
girls (ß = -589.9, p-value = 0.010) meanwhile this level was not significant for boys.  
Further, maternal blood Cd, As and Hg level were not significant with birth weight in 
either the overall or the stratified models.  
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In model 2 (table 6) including Pb and Cd at P2 due to its naturally relationship, the model 
was, based on the F-test, improved from the initial model. In this model, maternal blood 
Pb level was strongly associated ß=-573.83, p = 0.009) with birth weight for girls while 
for boys was not significant (p = 0.931) at all. While maternal blood Cd at P2 was border 
significant (p = 0.050) for boy’s counter wise not significant for girls.  
In the model 3 (table 7) including only Pb at P2 and adjusted for the selected relevant 
variables. Overall, a significant association between Pb with birth weight was observed 
(ß -359, p-value = 0.020) but when stratified, only an effect for baby girls (ß=-567.7, p-
value = 0.008) were found. We also built one model (model 5, table S1 in Supplementary 
file) including Pb adjusted for smoking habit of mother 6 months before pregnancy as a 
substitute for Cd. For girls, smoking reduced the effect of Pb on birth weight with 23% (p-
value = 0.039). Evaluating the F-test between model 2, 3 and 5, model 3 predicted the best 
model between Pb and birth weight. 
Simultaneously we also built a model 4 (table 8) to explore the birth weight by Cd alone 
adjusted for the selected covariates. We found significant association of Cd at P2 with 
birth weight in baby boys only (p-value = 0.045). Further, model 6 (table S2 in 
Supplementary file) with blood Cd at P2 adjusted for smoking habits was for boys 
borderline significant (p-value = 0.055). However, the association was not significant for 
the overall model. According to the F test, model 2 was, compared to model 4, less 
explained by its predictors.  
However, besides the gender, all the models suggested that maternal age, gender, parity, 
gestational age and height (only boys) (all p-value < 0.001) were strong predictors for the 
birth weight. They are positive explanatory factors for the birth weight. 
To conclude, multiple regression models adjusted for selected covariates, individual or in 
combinations, demonstrated statistically significant negative association of maternal 
whole blood Pb concentrations on birth weight for girls only; both in adjusted for all 
elements, adjusted for Cd, and adjusted for smoking habits and alone. According to the F-
test, model including Pb alone, stated the best model. Likewise, Cd at P2, was also a 
negative predictor of birth weight, but only for boys, and with no association when 
adjusted for smoking habits or Pb. No significant association of other toxic elements like 
As and Hg with birth weight were found in the multiple regression models. Moreover, we 
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built models with As and Hg alone and simultaneously adjusted for associated elements, 
but these elements remained non-significant (the data is not presented in the thesis). 
 
 
Table 5: Model 1- Association between maternal whole blood toxic elements Cd, As, Hg and Pb and birth weight adjusted 




Boy Girl  
Birth weight (gm) (n= 257) Birth weight (gm) (n=131)  Birth weight (gm) (n=126)  
 ß 95% Cl p-value ß 95% Cl p-value ß 95% Cl p-value 
Body weight at 2nd 



















Gender (boy/girl) −178.8 
−279.0 to 
−78.6 
0.001       





































































F 19.55   14.85   6.8   
R² .41   .49   .31   
P (over all) <.001   <.001   <.001   
Maternal body weight, height and blood sampling were taken at 18.2 weeks 
All the toxic elements concentration took in 3rd postpartum day (P2) except Hg which took in 2nd trimester (P1) 
Cd, As, Hg and Pb are log transformed (𝑙𝑜𝑔10
𝑥 ); and whole blood concentration   
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Table 7: Model 3- Association between toxic element Pb with birth weight adjusted for other selected covariates, in a 
multivariable  regression model – The MISA study (2007-2011) 
 Overall Boys Girls 
 Birth weight(gm) (n=257) Birth weight(gm) (n=131) Birth weight (gm) ( n=126)  
 ß 95% Cl p-value ß 95% Cl p-value ß 95% Cl p-value 
Body weight at 2nd 
trimester (kg) 
7.5 3.5 to 11.6 <0.001 8.8 3.2 to 
14.4 
0.002 5.9 .21to 11.7 0.042 
Height of Mother 
(cm) 
7.9 .02 to 15.9 0.049 13.1 2.1 to 
24 
0.019 1.2 −10.4to 
12.8 
0.837 
Gender (boy/girl) −179.7 
−278.3 to 
81.1 
0<.001       
Gestetional age (in 
days) 
















































Maternal body weight, height and blood sampling were taken at 18.2 weeks 
Pb in 3rd postpartum day (P2) is log transformed (log₁₀x) and whole blood concentratio 








Table 6:  Model 2- Association between toxic elements Pb, Cd and birth weight adjusted for other selected 
covariates, in a multivariable regression model – The MISA study (2007-2011) 
 Overall Boys Girls 
 Birth weight(gm) (n=257) Birth weight(gm) (n=131) Birth weight (gm) ( n=126)  























<0.001       
Gestetional 







<0.001 23.68 15.1 to 32.2 <0.001 


































F 25.16   19.95   9.1   
R² 0.41   0.49   0.31   
P (over all) <0.001   <0.001   <0.001   
Maternal body weight, height and blood sampling were taken at 18.2 weeks 
Cd and Pb in 2nd postpartum day(P2) are log transformed (𝑙𝑜𝑔10
𝑥 ); and whole blood concentration 
a gestetional age detect by ultrasound and parity count as nullipara to multipara. 
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Table 8: Table 8: Model 4 Association between toxic element Cd with birth weight adjusted for other selected 
covariates, in a multivariable regression model- The MISA study (2007-2011) 
 Overall Boys Girls 
 Birth weight(gm) (n=257) Birth weight(gm) (n=131) Birth weight (gm) n=(126)  





6,8 2.8 to 10.8 0.001 8.5  3 to 14.1 0.003 5.1 −.97 to 11.3 0.098 
Height of 
Mother (cm) 









0.001       
Gestetional 
age (in days) 
22.9 18.1 to 27.8 <0.001 21.6 15.7 to 27.4 <0.001 23.3 14.2 to 32.3 <0.001 
Parity (0-4) 



































Maternal body weight, height and blood sampling were taken at 18.2 weeks 
Cd in 3rd postpartum day (P2) is log transformed (𝑙𝑜𝑔10
𝑥 ) and whole blood concentration 
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4 Discussion 
4.1 Main findings 
                  
This study evaluated the association between selected toxic elements exposure to the 
North Norwegian mothers and birth weight of newborn babies. Concentrations of Pb, Cd, 
Hg and As both in the 2nd trimester and 3 days postpartum were evaluated against birth 
weight. All of the toxic elements peaked at P2 except Hg, which was highest at the P1 time 
period.  In multivariable models, those peaking elements were best to predict reduced 
birth weight. Stratified by gender, we revealed that an increasing maternal blood Pb 
concentration negatively influenced birth weight in baby girls. Besides, a high 
concentration of Cd in maternal blood increased the chances of reduced birth weight in 
baby boys when adjusted for alone. 
4.2  Predictors of the best model 
 
In this study, we examined the maternal whole blood concentration of selected toxic 
elements to attain the peaking level of these elements.  We expected that these peaking 
concentration would have the highest effect. Both P1 and P2 were tested in the models 
and with the peaking levels as the best models. In multivariable model 1 (table 5) where 
we used all the log transformed elements with peaking levels, it explains 41% variances 
by its covariates (according to F test). During the gestational period, lots of physiological 
and metabolic changes occur to meet this growth and development of the fetus. Changes 
include the expansion of the volumes of blood and its contents, substantial changes in 
circulating hormones, essential elements and serum lipids. Consequently, it is rational to 
assume variations of blood levels of toxic elements during the gestational and postpartum 
periods. [88]. Earlier, the authors have shown that the decrease in birth weight per 1-μg/L 
increase in elements was more significant at lower concentrations than at higher 
concentrations without evidence of a lower threshold of effect [94]. A superlinear dose-
response relationship, with the greatest decrement in birth weight occurring at the lowest 
level of Pb exposure, was predicted in a large data linkage study of Pb <100 μg/L [95]. 
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4.3 Gender difference in the models 
4.3.1 Lead 
 
 Models for Pb 
In this study, when we tested out the effects Pb separately (in model 3), it shows, Pb 
causing reduce birth weight in the baby girl (ß =–567.8, p-value=.008). Stratification by 
gender appeared to explain more of the variability. Interestingly in model 1 (all four 
elements), 2 (Pb and Cd), 3 (Pb alone) and S1 (Pb and smoking), maternal whole blood Pb 
at P2 were significant for girls but reversibly non-significant for boys. Moreover, when we 
adjusted Pb with smoking the association becomes weaker because smoking heightens 
the effect of Pb. On the other hand, in model 2 (Pb and Cd) maternal whole blood Pb at P2 
is significant for girls but not for boys since we have a high frequency for smoker mother 
of baby boys (22.5%). 
Gender difference 
 
Our study indicated that the adjusted maternal blood Pb levels (mean = 8.8 μg/L) were 
associated with statistically significant decrease in birth weight in baby girls (p-value = 
0.008) when it alone or adjusted for other log transformed elements or with smoking.  
Interestingly, this association has not been observed for boys. However, when the model 
for girls adjusted with Cd, it shows 9.8 % effect change of Pb 573 gm of reducing birth 
weight compare to 567 g for Pb alone. However, the effect on the β-estimate was rather 
small (<10 %) and thus, not considered as a confounder or modifier [96]. In contrast, the 
Pb model adjusted with smoking showed a 20% reduced effect (> 20%) of Pb on birth 
weight compare to adjustment for Pb alone. Since smoking contributes to Pb 
concentrations, the adjustment either may mask the total effect of Pb on birth weight or 
smoking may also act as a confounder due to other toxic effects of smoking on birth weight 
[18]. Hence, based on both the β-effect, p-value, and the F-test, the model which was 
adjusted with the birth weight for Pb alone may be preferable to observe the real effect of 
Pb. Even though the frequency of smoking has observed more in boy’s mother (22.5%) 
than in girl’s mother (11.6%), there were no effects of Pb on birth weight for baby boys. 
So, we also consider the finding may be by chance as sometimes we could not deny the 
null hypothesis or unable to exclude unexplained confounding which is not detected.  
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However, our particular interest about the gender effect can be explained by the biological 
mechanism. Only a few other studies demonstrate gender differences of Pb effect on birth 
weight [84, 97]. An epidemiological study on the newborn in Port Pirie, South Australia 
has shown that girls are more vulnerable to post-natal Pb exposure. The author explains 
some of the factors and reasons for the variation. One of the primary justifications behind 
the gender inconsistency is the timing of exposure. Biologically founded that girls develop 
earlier than boys during early childhood; there may be a greater intrinsic biological 
susceptibility for the gender difference in mother womb [97]. So, it could be a reason for 
baby girls in the womb have higher susceptibility by Pb from their beginning. One study 
about low birth weight and macrosomia from Northern Ethiopia showed that along with 
other variables regarding mother bearing female neonates are at higher risk to deliver 
low birth weight neonates [1].  However, other studies found uneven result from our 
study [98-100]. The study about associations between prenatal lead exposure and birth 
outcomes modification by sex and GSTM1/GSTT1 polymorphism showed a significant 
inverse association of maternal blood Pb with birth weight and head circumference in 
baby boys [98]. The impaired placental function caused by prenatal Pb exposure may put 
male fetuses in a more disadvantageous position due to their higher growth rate and 
greater demands for nutrients compared with females [100]. 
Contrast with other studies 
A counter association between prenatal Pb exposure and birth weight has been found in 
several studies. Three sequential longitudinal birth cohorts in Mexico City found that 
blood Pb concentration was correlated with lower birth weight with evidence that the 
decrease in weight is sustained until age 5[16, 71, 86]. A study about population included 
upstate New York found maternal Pb < 100 μg/L were associated with a small but 
statistically significant decrease in birth weight[95]. In another study of disadvantaged 
mother-infant pairs with a mean second trimester blood Pb level of 28 μg/L showed 
infants whose Pb levels changed from above to below the median were larger than infants 
whose Pb levels went from below to above the median[85]. 
In our study, a statistically significant (p = <0.001) rise in maternal blood lead from the 
P1 to P2 has been observed. Furthermore, research about the mobilization of lead from 
human bone tissue during pregnancy and lactation reports the geometric mean (GM) of 
blood Pb approximately 29 μg/L in Australian women.  They calculated the rise in blood 
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Pb through the term of the whole pregnancy and found that blood Pb increases about 20% 
from the second trimester to delivery[101]. In contrast, in our study north Norwegian 
mothers has quite low levels of Pb in the 2nd trimester (P1) 7.5 μg/L and 3rd postpartum 
day (P2) 8.8 μg/L. Therefore, we calculated the Pb rise in blood through the 2nd trimester 
of pregnancy to 3rd postpartum day and found that blood Pb increases <10% from the 
second trimester to delivery [88]. Similar to our finding,  previous evidence shows that 
even at very low levels, maternal blood Pb throughout pregnancy and the transportation 
of blood Pb from mother to child does not occur at random. It follows superlinear dose-
response patterns established in cohorts with higher lead levels [95]. Moreover, in the 
earlier study by Taylor, the authors suggest that the decrease in birth weight per 1-μg/L 
increase in Pb was more significant at lower concentrations than at higher concentrations 
without evidence of a lower threshold of effect [75] 
Safe levels 
 
Pb is a readily permeable toxic element, and the adverse effects of low-level prenatal Pb 
exposure are associated with negative impacts in early childhood and later life [32]. 
Although in the case of low levels (mean= 8.8 μg/L), we have seen an effect of Pb on birth 
weight and the low contribution of the variation of birth weight. Health Canada has described 
the margin of safety between exposures and effects, giving sufficient evidence that health 
effects occur below 100 μg/L. Moreover, health effects have been associated with Pb level 
even as low as 10-20 μg/L [95, 102]. So, these reports provide evidence that the safety 
level for Pb is either very narrow or nonexistent [103-105]. Whereas, the CDC published 
a statement indicating that there is no threshold below which Pb exposure is acceptable. 
Later they have requested explicitly for additional research into pregnancy outcomes 
related to prenatal exposure [106].  
4.3.2 Cadmium 
 
Model for Cd 
 
In this study, Cd had significant (p-value = 0.045) role in reducing baby boys’ birth weight 
when adjusted for alone. But when Cd adjusted for smoking habits before pregnancy then 
there is no longer association with birth weight, meaning that smoking variable masks the 
effects of Cd on birth weight. By contrast, when Cd adjusted for smoking habits before 
pregnancy the effects of Cd on birth weight was elevating in model S2 (ß =−296.3, p-
 
Page 36 of 51  
value=0.055) than in the Cd only model 4 (ß =−287, p-value=0.045). However, the effects 
of Cd on birth weight tremendously elevated but significance level reached into no 
significance. When we adjusted the model Cd with the smoking variable the effect of Cd 
disappeared, and hence, was modified by the smoking variable. Therefore, the Cd was no 
longer associated with birth weight. Hence, smoking was not associated with birth weight 
[107].   
Gender difference 
 
In our study, 22.5% of pregnant women carrying baby boy smoke during the pregnancy, 
while this is 11.6% for the pregnant women carrying baby girls. For that reason, when we 
run a model for Cd alone it shows the association. However, when we adjusted the model 
Cd with smoking variable the effect of Cd disappeared, this was probably modified by the 
smoking variable. Therefore, Cd has no association with birth weight. In contrast, other 
studies found the most distinct consequences of cigarette smoking during pregnancy like 
restrictions to fetal growth, low birth weight, reduced fetal length, head circumference. 
These effects are stronger for male offspring [85, 86]. Additionally, the male fetus carrying 
women who smoke more than a ½ packet of cigarettes per day delivered neonates with 
reduced birth weight and smaller in size. However, we could not relate this observation 
to baby girls [85].  
One explanation for gender susceptibility for Cd could be an increased intrauterine 
growth velocity in the male fetus than in females. So, it might be more vulnerable for 
growth retardation in the male fetus [85]. Additionally, the gender differences in the 
hormonal background could be an important consideration. High levels of 
gonadotrophins and testosterone appear in the male fetus in the second trimester. 
Further, the important barrier mechanism like skin barrier and lung maturation process 
is delayed in the male fetus while comparing to a female fetus. Estrogen accelerates the 
barrier process, while testosterone delays development of the barrier mechanism [108]. 
In contrast, some studies found the association of maternal blood Cd level with birth 
weight in baby girl [75, 93]. It has also been reported in few studies that the negative effect 
of maternal smoking in pregnancy is more pronounced in males than in females [33, 85, 
86]. The author provides possible explanations about the effect of prenatal glucocorticoid 
exposure, which is appeared to be sex specific. Mothers, receiving glucocorticoid 
treatment, for asthma, 11β-HSD2 activity was significantly decreased in placentas of 
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female but not in male fetuses. This reduced 11β-HSD2 activity was associated with 
increased umbilical cord blood cortisol levels as well as,  birth weight can be reduced in 
the female fetus[62]. In other epidemiologic studies, the authors explained that Cd might 
also interfere with the insulin-like growth factor (IGF) axis and thereby may reduce fetal 
growth in a sex-specific manner [109, 110]. In human pregnancies, both IGF-1 and insulin-
like growth factor-binding protein 3 (IGFBP-3) are positively associated with birth weight 
[68]. Furthermore, the studies have found that IGF-1 and IGFBP-3 levels in umbilical cord 
blood/plasma were higher in female than in male infants[109, 110]. 
Contrast with other studies 
 
Maternal blood Cd levels were significantly associated with the reduced birth weight of 
baby boys (p-value=0.045). Other studies also reported that maternal blood Cd has 
associations with newborn birth weight[111].   There is abundant evidence showing that 
maternal active smoking during pregnancy profoundly alters placental weight, 
morphology, and function [56, 112]. In our study, most of the pregnant women (22.5%) 
carrying boy smokes during the pregnancy than women who carrying girl (11.6%). Cd is 
not an essential element in humans, but due to a variety of industrial and other 
anthropogenic activities, it becomes one of the primary heavy metal contaminants in the 
environment. In our study, the peak mean concentration of Cd for smoker was 0.56 μg/L. 
But mother’s whole blood concentration does not represent the fetal exposure. Some 
researchers claim a threshold value for the passage of Cd through the placenta.  It seems 
that the human placenta serves as a selective barrier to Cd with an average attenuation of 
40–50% [113]. However, other studies reveal cord blood Cd was only about 10% of that 
in maternal blood, confirming the findings of other studies that placenta acts as a 
relatively impermeable barrier to this element[114, 115]. Some research has also shown 
that maternal smoking during pregnancy can promote Cd accumulation in the placenta. 
However, those placental Cd concentrations are inversely correlated with neonates' birth 





In this study, we observed the peaking levels for both smoker and non-smoker at P2 time 
point. For the smoker, the mean value was 0.56 µg/L and for non-smokers 0.17 µg/L. The 
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margin of safety of exposures has been described by Federal Environmental agency, 
Germany. The reference value for non-smoking adults aged 18–69 years is 1 µg/L[117]. 




Model for Hg 
 
In our study, Hg was not associated with birth weight alone or adjusted by other log 
transformed elements (p-value=0.661). Some studies are constant with our study as they 
found no association between birth weight and maternal blood or cord blood Hg [53, 118]. 
Some other studies have found a negative association between Hg exposure and birth 
weight [51, 52]. However, high maternal blood Hg levels also a reason for association with 
low birth weight[119]. 
Contrast with other studies 
 
We have not found any significant relationship between maternal blood Hg with birth 
weight. Similar to our study, some other studies also do not support the relationship 
between Hg exposure and birth weight [53, 118]. A study in a fishing community in 
Denmark found that total Hg in neither cord nor maternal blood was related to newborn 
size [11]. A recent British study showed that total Hg levels in umbilical cord blood were 
not related to birth weight [30]. Genetic predisposition, dietary patterns, the difference in 
concentrations and environmental factors could be the reasons behind the differences 
among studies [120, 121]. However, some studies found an inverse association between 
birth weight and prenatal Hg exposure in Poland and South Korea, and some studies 
suggest possible effects on child growth afterward [13]. Norwegian Mother and Child 
Cohort Study (MoBa) relates the dietary Hg exposure negatively with the birth weight of 
offspring significantly. They have stated that the highest exposure group has an increased 
risk of giving birth to babies being small for gestational age (SGA). If we compare the mean 
blood Hg level with our study, we found quite lower value 1.21 µg/L than MoBa study 
(1.88 µg/L) for pregnant women [52]. Birth cohort in Mexico City reported mean average 
blood Hg level for pregnant women 3.4 µg/L [121, 122]. A potential dose-response 
relationship between mercury exposure and adverse reproductive outcomes like the low 
birth weight has been mentioned by this publication [123]. Thus it is evident that high Hg 
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level relates with birth weight. Unlike MISA study group (n=282), MoBa study group 
which is also from the same location where the participation level was quite high, and the 
Hg level is also a bit higher from our participants level (n=62,941, MoBa level 1.88 
µg/L)[52]. People in the Arctic region are usually exposed to Hg mainly through seafood 
consumption. Other sources, such as elemental Hg in the air and inorganic Hg in food 
items are minor sources of exposure. Consequently, the highest exposure levels to 
methylmercury (MeHg) in the Arctic region are found in coastal populations who 
consume more fish on a regular basis. These fishes are mainly top on the food chain like 
the whale, shellfish and freshwater fish [124]. Mercury levels in fish vary greatly 
according to species and origin [87]. Farmed fish generally contain less Hg than free-
ranging fish from the open ocean. The highest values have been reported for wild fish 
catches in the Mediterranean Sea [87]. One important plausible mechanism for Hg 
exposure results decrease in birth weight via oxidative stress. Hg has been reported to 
cause oxidative stress, which may lead to lipid peroxidation and the generation of reactive 
oxygen. The study also suggested that heavy metals, such as Hg might induce oxidative 
stress caused by changes in the GSH and ATP metabolism [50]. However, in this study the 
participants of these food groups are low due to Norwegian national dietary advice 
regarding fish and seafood intake especially for pregnant and lactating women could be 
one of the reasons [19].   
Safe levels 
In this study, the mean Hg level 1.21 µg/L have been observed at P1 time point. The mean 
value is lower than the recommended value by Federal environmental agency, Germany 
which is 2.0 µg/L[117]. However, Safe levels for women at reproductive age 
recommended by US environmental protection agency is slightly higher than Federal 
environmental agency, Germany. The cut-off level for women is 5.8 µg/L [46, 117]. 
However, the joint FAO/WHO Expert Committee on Food Additives established the 
recommended safe level for Hg as Provisional Tolerable Weekly Intake (PTWI), which is 
1.6 µg of MeHg/kg body weight per week [125]. 
4.3.4 Arsenic 
 
Model for As 
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In our study, we did not find any association of As alone or adjusted for other log 
transformed elements with birth weight (p-value = 0.414), neither overall nor stratified 
by gender. In this study, the form of the As is a non-toxic form called inorganic arsenic 
[21]. This inorganic As methylate into the body and quickly passes through urine. 
Similarly, fish consumption was a positive predictor of blood As concentrations (p < 0.01) 
among women from our previous finding in the North Norwegian Mother-and-Child Study 
[21]. On the other hand, other studies where the As is in the toxic form found a significant 
association of As with birth weight, IUGR and small fetus [40, 41, 44]. Further, other 
studies have demonstrated that maternal high As exposure (measured by urinary total 
arsenic concentrations) is associated with birth weight, birth length, and risk of SGA for 
baby girls only [44, 126]. 
 
Contrast with other studies 
 
We did not find any association between As and birth weight in the study group. Similar 
to our study other studies from China also did not find any association between mother 
blood As and birth weight [5, 44].  However, the link between As exposure and its effect 
on birth weight is established in many studies [35, 41, 42, 127]. One prospective cohort 
study from Ottawa County, Oklahoma estimated negative associations between maternal 
blood arsenic concentrations and birth outcomes while adjusting for exposure to Pb and 
Mn. However, their dietary source was different from our population [127]. Additionally, 
some studies found strong connection of As exposure during pregnancy and its 
association with fetal loss, small size at birth, infant morbidity and mortality [43, 128]. In 
other population, researchers have found that maternal blood As is significantly 
interrelated with birth weight.  The reason behind this interrelation is due to higher As 
levels and metabolites in, different form and various sources [19, 129]. The mechanism of 
As and growth retardation involved pathways mediated via gestational age as well as 
pathways independent of gestational age. As has a possible role of shortening of gestation 
and intrauterine growth restriction. The biologic effects of inorganic As exposure support 
the biological plausibility of findings. As can generate reactive oxygen species and deplete 
antioxidant enzymes (e.g. glutathione) which leads to oxidative stress. Oxidative damage 
in early pregnancy can disrupt placental development, function and cause alteration, 
afterward which is responsible for hamper oxygen and nutrient supply to the growing 
fetus. Further, it also reasons for interruption of production and metabolism of fetal 
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growth regulating hormones leading to preterm delivery and IUGR [41]. Another 
acceptable explanation is epigenetic alterations. Prenatal arsenic exposure has been 
found associated with deregulation of microRNA expression profiles in umbilical cord 
blood and DNA methylation status in maternal and umbilical cord blood. MicroRNAs have 
an important role in normal placental development; and alteration of microRNA 
expression profiles have been associated with abnormal placentation and SGA births [42, 
43].  As has a very common source which is fish, the person with the highest level of 
arsenic also had the highest level of fish consumption. Most of the blood As is in the form 
of arsenobetaine, which is considered nontoxic form, also able to passes readily (half-life 
is hours) [14]. In Norway, As, we detect in maternal blood, is nontoxic (arsenobetaine) 
organic form and also present in relatively low concentration [21, 88, 115]. Thus, we 
assumed that no clarifications are needed for its risk measurement.  
Safe levels 
According to WHO provisional guideline the safe levels for As is 10 μg/L[37] . This level 
is only for drinking water. While in our study the highest mean As was 1.74 μg/L which 
is far less than WHO recommended level. However, in North Norway main source of As 
is seafood in the form of arsenobetaine and nontoxic form [88, 115].  
4.4 Effect of covariates on birth weight 
 
Demographic characteristics are found to be associated with birth weight in other studies 
[79]. In our study maternal age, height, weight, BMI, parity, gestational age and gender of 
the baby has significantly associated with birth weight. Maternal body weight, gestational 
age, and parity were a recurring positive explanatory variable in all multivariable linear 
models. Gender plays an interesting role in birth weight. The reverse relation reveals that 
baby boys are more prone to low birth weight. However, boys appear to be heavier than 
girls respectively 3739 gm and 3566 gm. This result is confirmed by the preliminary 
report from the MISA cohort study [21]. These three predictors (gestational age, parity, 
and gender) for birth weight are well established[130]. Other cohorts, establish parity as 
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4.5 Strength and Limitation of the study 
 
The strength of the study is that it has prospective longitudinal aspects. In our study, we 
collected data at a specific time point, namely at 2nd trimester (P1) and 3rd postpartum 
day (P2). For prospective aspect, we collected the baseline data from the day of 1st visit 
and afterward we collected the data from the follow-ups. During follow-ups, sample 
collections were done [90]. Since an objective of this study was to detect patterns of 
change in the concentrations of the selected toxic elements during gestational periods to 
detect the highest concentration throughout the period, external validity, in this case, 
maybe less critical. On the other hand, the statistically different concentration of the toxic 
elements through the P1 and P2 validated the strength of the study by choosing the best 
model [88]. Another strength of the study is that data for mother and newborn 
characteristics have been obtained from the Medical Birth Registry of Norway (MBRN). 
Confounding usually measured as bias and often termed as mixing or blurring of effects. 
It commonly happens when the effect of an exposure intends to determine the occurrence 
of an outcome. But then actually it measures the effect of another factor, a confounding 
variable. In this study, we controlled for several factors like age, gestational age, parity, 
gender of the baby including smoking as a confounder for elements or predictors of birth 
weight. This cofounder, smoking, is suspected to hide the actual effect of Cd on birth 
weight. Confounding can also be controlled by adjusting it after completing a study using 
stratification or multivariate analysis[96]. Here, in this study, we ran several 
multivariable models with or without adjusting the smoking variable and at the end 
stratified by gender. As our study population is quite small, the model was not further 
stratified into a smoking group. But we controlled for several factors, which have an 
influence on birth weight. However, we might have missed adjusting for some relevant 
confounders related to elements or interaction terms. 
Selection bias is actually termed as non-distinction and refers to a selection pattern where 
the dependence of the outcome category is conditional on across exposure categories 
[131, 132]. It is assumed that non-differential selection is rather harmless and does not 
cause serious bias. Nevertheless, if any dependence on the outcome category is not 
consistent across exposure categories then a termed called differential in selection or bias 
of estimation may arise. Selection bias due to loss to follow- up is also known as 
informative censoring. But in our previous report we have demonstrated relatively high 
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follow-ups, but bias can’t be ruled out[21]. The selection bias could be controlled by the 
techniques such as stratification-based methods, weighted methods.  
The study group was smaller than targeted even though enthusiastic campaign strategy 
like advertising through media, posters, web publications, encouragement by health 
professionals and field workers, etc. have been executed. Although several attempts were 
made to increase the participant's rate, the acceptance rate was slow-moving. So, this 
inescapable low participation rate can be a limitation. Study tiredness (request the 
participants for too many studies) among those eligible members were visible. The final 
sample size was less than targeted. Therefore, the study is likely less representative as 
small numbers might have reduced the chance of detecting a real effect. Another 
drawback of this study is involving a high percentage of older well-educated women than 
the MBRN registered mother that could further lead to selection bias [90, 132]. Because 
well-educated women are more aware of healthy food selection including fish [118] . 
Moreover, a direct comparison of the 262 subsets of the current study with the full cohort 
(n = 515) indicated lower mean for educational level average (15.6 and 15.9), but in 
contrast higher parity (respectively 1.8 and 1.0) and age (31.6 and 31.0). This is 
encouraging in terms of internal validity. The decision to analyze a subset of the study 
population has reduced the statistical impact of the result and thus places some restraint.     
Information bias in general is a result of measurement errors. For the outcome variable 
birth weight, we collected data from MBRN with no missing data which is a strength of 
the study. However, for the measurement of birth weight, no standardized equipment was 
supplied, but measured by local hospital own electronic or beam scale. Hence different 
weight scale and human error may introduce to measurement bias. Self-reported 
information may have a high degree of intrinsic improbability. For example, the self-
reported smoking habit has more probability for under report, likewise the FFQ and 
calculation of the amount of food may be under or over reported relying on the grade of 
healthy content.  Another thing is the null value or smallest amount attribution on missing 
value could lead underestimation and misclassification [133]. Another type of bias of our 
concern is recall bias by the members to assemble FFQ or other lifestyle habits. A selective 
memory could lead to underreporting or overestimation. To minimize the recall bias FFQ 
focuses foods consumption on regular basis, so that it helps to identify consumers’ trend 
in the population but still other factors could lead to bias. Further, and in addition to a 
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larger study group, a more sophisticated analysis may have brought more strengths into 
the results; and also including the mixture effect of elements. Essential elements, not 
included in this study, are due to the limitation of the content. But we have the concern 
about the influence of essential elements on the toxic elements; e.g. regulation of uptake, 
distribution and toxic effects [88]. 
4.6 Conclusion 
 
A significant inverse association was found between maternal Pb concentration and birth 
weight in female neonates only. This significant correlation confirms the potential for sex 
response differences to Pb exposure. The relationship of maternal Cd concentration with 
birth weight in male neonates is reverse, but not for female neonates. However, when Cd 
is adjusted for smoking the relationship was not significant anymore. Further, we found 
a significant rise of toxic elements from P2>P1 except for Hg (P2<P1). This ascending 
pattern of maternal blood toxic elements establishes the maternal physiological and 
metabolic changes during pregnancy, at delivery and after delivery. Although the 
measured maternal concentrations of the toxic contaminants were relatively low, more 
substantial exposures would be a concern. This is especially a worry for mothers who 
smoke cigarettes during pregnancy. 
Based on our findings, we emphases the significance of biomonitoring studies for 
reporting the gender differences for different toxic elements. From a public health 
perspective, we appraise the biomonitoring study as an important tool for organizing 
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Table S1: Model 5- Association between toxic element Pb with birth weight adjusted for other selected covariates, in 
a multivariable regression model- The MISA study (2007-2011) 
 Overall Boys Girls 
 Birth weight(gm) (n=257)  Birth weight(gm) (n=131) Birth weight(gm) (n=126) 
 ß 95% Cl P-value ß 95% Cl P-value ß 95% Cl p-value 
Body weight at 




0.001 8.1 2.2 to 13.8 0.007 5.5 .24 to 11.8 0.054 


























Parity (0-4) 149.9 100.9 to 
198.87 
<0.001 146.5 76.3 to 
216.8 
<0.001 158.2 79.5 to 
220.8 
<0.001 
Smoking for 6 
before pregnancy 
−10.29 −129.4 to 
108.8 
0.865 −66.4 −228.2 to 
95.4 
0.418 61.2 −358.5 to 
196.04 
0.502 






























Maternal body weight, height and blood sampling were taken at 18.2 weeks 
Pb in 3rd postpartum day (P2) is log transformed (𝑙𝑜𝑔10
𝑥 ); and whole blood concentration 
aGestetional age detect by ultrasound and parity count as nullipara to multipara. 




Table S2:Model 6- Association between toxic element Cd with birth weight adjusted for other selected covariates, in a 










Birth weight(gm) (n=257) Birth weight(gm) (n=131) Birth weight(gm) (n=126) 
  
  
ß 95% Cl p-value ß 95% Cl p-value ß 95% Cl p-value 
Body weight at 2nd 
trimester (kg) 
6.3 2.3 to 10.4 0.002 7.6 1.9 to 13.4 0.009 4.5 −1.1 to 
10.3 
0.118 
Height of Mother 
(cm) 
8.8 0.71 to 17 0.033 15.7 4.2 to 27.2 0.008 1.3 −10.3 to 13 0.825 
Gender (boy/girl) −179.8 −279.4 to 
−80.2 
<0.001 
      
aGestetional age (in 
days) 
22.8 1797 to 27.8 <0.001 23 16.3 to 
29.2 
<0.001 22.4 13.9 to 
30.9 
<0.001 
Parity (0-4) 155.8 106 to 205 <0.001 151.8 82.3 to 
221.2 
<0.001 159.1 86. to 
232.1 
<0.001 




0.681 −13.1 −182.1 to 
155.8 
0.878 87.9 −110.1 to 
285.9 
0.381 
Whole blood lg 
cadmium in p2 
−231.2 −469.6 to 7.2 0.057 −297.3 −600.3 to 
6.2 





















Maternal body weight, height and blood sampling were taken at 18.2 weeks 
Cd in 3rd postpartum day (P2) is log transformed (𝑙𝑜𝑔10
𝑥 ); and whole blood concentration 
aGestetional age detect by ultrasound and parity count as nullipara to multipara. 
Smoking status is yes/no 6 months before pregnancy. 
 
    
APPENDICES 
Appendix 1 Spørreskjema MISA 
Appendix 2 MISA LAB følgeskjema 
Appendix 3 27.03.2007 REK 







Universitetet i Tromsø Romssa universitehta
1
MILJØGIFTER I SVANGERSKAPET OG I AMMEPERIODEN
Vi ber deg fylle ut spørreskjemaet så nøye som mulig.
Skjemaet skal leses optisk. Vennligst bruk blå eller sort penn. Du kan ikke bruke komma, forhøy 0,5 til 1. 
Bruk blokkbokstaver.
Dersom du får for liten plass på enkelte spørsmål, vennligst noter på siste side, eller ta i bruk et ekstra ark.
Venligst besvar skjema innen en uke etter oppstart i prosjektet. Sendes sammen med blodtrykkssjema 
til UiT i vedlagte returkonvolutt.
SOSIALE FORHOLD
Dato for utfylling av spørreskjema: dag mnd år
Dato .........................................................................................
Hva er ditt postnummer? ..........................................................
Hva er ditt fødselsår:......................................................................
Hvor mange års skolegang/utdanning har du i alt, 
ta også med grunnskole og videregående? Antall år
Hvor mange personer er det i ditt hushold? Voksne Barn
Hvor høy er den samlede bruttoinntekten i ditt hushold?
c Under 150 000 kr c 601 000-750 000 kr
c 150 000-300 000 kr c 751 000-900 000 kr 
c 301 000-450 000 kr c Over 900 000 kr
c 451 000-600 000 kr
Hva er ditt yrke?
.........................................................................................................................................................................................
(Ikke skriv her ‡) 
Beskriv kort din arbeidsplass og arbeidsoppgaver så 
nøyaktig som mulig:
(Eksempel: skole/undervisning, sykehus/ pasientarbeid/cellegift, 
butikk/ klær, renseri/renser klær, kontor/dataarbeid, frisør/kunder)
.........................................................................................................................................................................................
(Ikke skriv her ‡) 
Hva er din arbeidssituasjon? (Sett om nødvendig flere kryss)
c Arbeider heltid c Arbeidssøkende
c Arbeider deltid c Under attføring
c Hjemmeværende c Uføretrygdet
c Under utdanning
OPPVEKST
Hva var din bostedskommune da du ble født, og i hvilke 
kommuner i Norge har du bodd lengre enn ett år?









I Nord-Norge bor det folk med ulik etnisk bakgrunn. Det vil si at de 
snakker ulike språk og har ulike kulturer. Eksempler på etnisk bakgrunn 
eller etnisk gruppe er norsk, samisk og kvensk.
Hvilket hjemmespråk har/hadde du, dine foreldre og 
besteforeldre? (sett ett eller flere kryss)
Norsk Samisk Kvensk Annet Vet ikke
Dersom annet 
beskriv
Morfar ....... c c c c c .....................................................
Mormor ... c c c c c .....................................................
Farfar.......... c c c c c .....................................................
Farmor ...... c c c c c .....................................................
Far ................ c c c c c .....................................................
Mor .............. c c c c c .....................................................
Jeg selv ... c c c c c .....................................................
Hva er din, din fars og din mors etniske bakgrunn? 
(sett ett eller flere kryss)
Norsk Samisk Kvensk Annet Vet ikke
Dersom annet 
beskriv
Min bakgrunn .... c c c c c ..............................................
Mors bakgrunn . c c c c c ..............................................
Fars bakgrunn ... c c c c c ..............................................
Er du sykemeldt? (Sett ett kryss i hver kolonne)
c Nei Hvordan er du sykemeldt?
c Delvis sykemeldt c Sykemeldt korttids
c Fullt sykemeldt c Sykemeldt langtids
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Hva regner du deg selv som? (sett ett eller flere kryss)
Norsk Samisk Kvensk Annet Dersom annet beskriv
c c c c ....................................................................................................
VEKT 
Hvor mye veide du før svangerskapet? (I hele kg) ....
Hva var din egen fødselsvekt som nyfødt baby?
 (Gram)    Vet ikke c 
Har du noen gang hatt vekttap på 5 kg eller mer, i så fall hvor 
mange ganger?
c Ja c Nei Antall ganger
RØYK OG ALKOHOL
Dersom du røyker daglig eller tidligere har røykt 
daglig, hvor mange år har du da røykt til sammen? Antall år
Er du til daglig utsatt for passiv røyking?
c Ja c Nei Antall timer daglig 
Er du totalavholdskvinne?
c Ja c Nei
Hvis NEI, hvor ofte og hvor mye har du drukket før dette svangerskapet?















Lettøl/cider (0,5 l) ............................. c c c c c c c
Øl/rusbrus (0,5 l) .............................. c c c c c c c
Vin (glass) ................................................ c c c c c c c
Brennevin (drink/shot) .................... c c c c c c c
Likør/Hetvin (glass) ........................ c c c c c c c
Dersom NEI, hvor ofte og hvor mye har du drukket i dette svangerskapet?















Lettøl/cider (0,5 l) ............................. c c c c c c c
Øl/rusbrus (0,5 l) .............................. c c c c c c c
Vin (glass) ................................................ c c c c c c c
Brennevin (drink/shot) .................... c c c c c c c
Likør/Hetvin (glass) ........................ c c c c c c c
Svært lite Svært mye
Alder 1 2 3 4 5 6 7 8 9 10
14 år.......................... c c c c c c c c c c
Før svangerskapet ..... c c c c c c c c c c





Ammet din mor deg da du var baby?
c Ja c Nei
Dersom JA, hvor mange måneder til sammen fikk du morsmelk?
Totalt antall mnd. med morsmelk    Vet ikke c 
Oppfatter du din helse som:
c Meget god c God c Dårlig c Meget dårlig
Vi ber deg angi din fysiske aktivitet etter en skala fra svært liten til svært 
mye ved 14 års alder, før svangerskapet og i dag. Skalaen nedenfor går 
fra 1-10. Med fysisk aktivitet mener vi både arbeid i hjemmet og i 
yrkeslivet samt trening og annen fysisk aktivitet som turgåing ol.
TRAN, OMEGA-3 OG FISKEOLJE
Bruker du flytende tran/omega-3/fiskeolje?
c Ja c Nei
Hvis JA, hvor ofte tar du flytende tran/omega-3/fiskeolje? 









Om vinteren ......................................................................... c c c c c
Resten av året .................................................................... c c c c c
Var dette svangerskapet planlagt?
c Ja c Nei
Dersom JA, hvor mange måneder tok det før du ble gravid?
Antall mnd. 
Trengte du hjelp til å bli gravid i dette svangerskapet? 
(Behandlet for barnløshet; hormonstimulering, IVF, mikroinjeksjon ol.)
c Ja c Nei
Beskriv dine røykevaner før og i dette svangerskapet? 
(Sett ett kryss)
Ikke røyker Av og til Daglig
6 mnd før svangerskapet ........................ c c c
Ved svangerskapets start ........................ c c c
I dag ............................................................................ c c c
Dersom du røyker eller har røykt, angi antall pr. dag eller pr uke?
Antall pr dag Antallpr uke
6 mnd før svangerskapet ............................................................
Ved svangerskapets start ............................................................
I dag ................................................................................................................
Dersom JA, hva var årsaken?
.........................................................................................................................................................................................




Påvirker noen av følgende forhold kostholdet ditt? 
(Sett om nødvendig flere kryss)
c Er vegetarianer/veganer c Har anoreksi
c Spiser ikke norsk kost til daglig c Har bulimi
c Har allergi/intoleranse c Prøver å gå ned i vekt
c Kronisk sykdom c Lav glykemisk mat
Vi er interessert i å få kjennskap til hvordan kostholdet ditt er vanligvis. 
Kryss av for hvert spørsmål om hvor ofte du i gjennomsnitt siste året har 
brukt den aktuelle matvaren, og hvor mye du pleier å spise/drikke hver gang. 
DRIKKE
Hvor mange glass melk drikker du vanligvis av hver type? 













Helmelk (søt, sur) ............................................... c c c c c c
Lettmelk (søt, sur) .............................................. c c c c c c
Ekstra lettmelk ................................................... c c c c c c
Skummet (søt, sur) ........................................... c c c c c c
Hvor mange kopper kaffe/te drikker du vanligvis av hver sort? 















Kokekaffe................................................ c c c c c c c
Traktekaffe ............................................. c c c c c c c
Pulverkaffe ............................................ c c c c c c c
Presskanne kaffe ...................... c c c c c c c
Anne kaffe (latte, espresso ol.) .... c c c c c c c
Svart te ..................................................... c c c c c c c
Grønn te .................................................. c c c c c c c
Bruker du følgende i kaffe eller te:
Kaffe Te
Sukker (ikke kunstig søtstoff) ............... c Ja c Nei c Ja c Nei
Melk eller fløte ......................................... c Ja c Nei c Ja c Nei















Springvann/flaskevann ............. c c c c c c c
Hvor mange glass juice, saft og brus drikker du vanligvis? 













Appelsinjuice ..................................................... c c c c c c
Annen juice .......................................................... c c c c c c
Saft/brus med sukker ................................. c c c c c c
Saft/brus sukkerfri ......................................... c c c c c c
YOGHURT/KORNBLANNING
Hvor ofte spiser du yoghurt (1 beger)? (Sett ett kryss)
c Aldri/sjelden c 2-3 pr. uke
c 1 pr. uke c 4+ pr. uke
Hvor ofte spiser du kornblanding, havregryn eller müsli? 
(Sett ett kryss)
c Aldri/sjelden c 4-6 pr. uke
c 1-3 pr. uke c 1+ pr. dag
KOSTTILSKUDD
Bruker du kosttilskudd?
c Ja c Nei










......................................................................................................... c c c c c
......................................................................................................... c c c c c
......................................................................................................... c c c c c
......................................................................................................... c c c c c
Bruker du kapsler/piller med tran/omega-3/fiskeolje?
c Ja c Nei
Hvis JA, hvor ofte tar du kapsler/piller med tran/omega-3/fiskeolje 









Om vinteren ......................................................................... c c c c c
Resten av året .................................................................... c c c c c
Hvilken type kapsler/piller med tran/omega-3/fiskeolje bruker du 




Hvor mange skiver brød/rundstykker og knekkebrød/
skonrokker spiser du vanligvis? 













Grovbrød ................................................................ c c c c c c
Kneip/halvfint .................................................... c c c c c c
Fint brød/baguett............................................ c c c c c c
Knekkebrød o.l.  .............................................. c c c c c c
BRØDMAT
Hvilken type flytende tran/omega-3/fiskeolje bruker du vanligvis, og 
hvor mye pleier du å ta hver gang? 
1 ts ½ ss 1+ ss
Navn:.......................................................................................................................... c c c
Navn:.......................................................................................................................... c c c
Navn:.......................................................................................................................... c c c
4
Nedenfor er det spørsmål om bruk av ulike påleggstyper. Vi spør om 
hvor mange brødskiver med det aktuelle pålegget du pleier å spise. 
Dersom du også bruker matvarene i andre sammenhenger enn til brød 
(f. eks. til vafler, frokostblandinger, grøt), ber vi om at du tar med dette 
når du besvarer spørsmålene.
Hva slags fett bruker du vanligvis på brødet?
c Bruker ikke fett på brødet
c Smør
c Hard margarin (f. eks. Per, Melange)
c Myk margarin (f. eks. Soft, Vita, Solsikke)
c Smørblandet margarin (f.eks. Bremyk)
c Brelett
c Lettmargarin (f. eks. Soft light, Letta, Vita Lett)
c Middels lett margarin (f. eks. Olivero, Omega)
Dersom du bruker fett på brødet, hvor tykt lag pleier du 
å smøre på? (En kuvertpakke med margarin veier 12 gram). 
(Sett ett kryss)
c Skrapet (3 g) c Godt dekket (8 g)
c Tynt lag (5 g) c Tykt lag (12 g)
FRUKT OG GRØNNSAKER















Epler/pærer .......................................... c c c c c c c
Appelsiner o.l.  ................................. c c c c c c c
Bananer ................................................... c c c c c c c
Annen frukt........................................... c c c c c c c















Gulrøtter .................................................. c c c c c c c
Kål ................................................................ c c c c c c c
Kålrot ......................................................... c c c c c c c
Brokkoli/blomkål ............................ c c c c c c c
Blandet salat ....................................... c c c c c c c
Tomat ......................................................... c c c c c c c
Grønnsakblanding (frossen) .... c c c c c c c
Løk ............................................................... c c c c c c c
Andre grønnsaker .......................... c c c c c c c
For de grønnsakene du spiser, kryss av for hvor mye du 
spiser hver gang: (Sett ett kryss for hver sort):
Gulrøtter (stk) ..................................................... c ½ c 1 c 1 ½ c 2+
Kål (dl) ..................................................................... c ½ c 1 c 1 ½ c 2+
Kålrot (dl) .............................................................. c ½ c 1 c 1 ½ c 2+
Brokkoli/blomkål (buketter) .................... c 1-2 c 3-4 c 5+
Blandet salat (dl) ............................................ c 1 c 2 c 3 c 4+
Tomat (stk) ............................................................ c ¼ c ½ c 1 c 2+
Grønnsakblanding (frossen) (dl) .......... c ½ c 1 c 2 c 3+
RIS, SPAGHETTI, GRØT, SUPPE
Hvor ofte bruker du ris og spaghetti/makaroni? 










Ris ................................................................................................ c c c c c
Spaghetti, makaroni, nudler ................................ c c c c c
Hvor ofte spiser du grøt? 













Risengrynsgrøt ................................................. c c c c c c
Annen grøt (havre o.l.) ................................... c c c c c c
Hvor ofte spiser du suppe? 











Som hovedrett ................................................................... c c c c c
Som forrett, lunsj eller kveldsmat .................. c c c c c
FISK













Syltetøy .................................................................... c c c c c c
Brunost helfet .................................................... c c c c c c
Brunost halvfet/mager ............................... c c c c c c
Hvitost helfet ...................................................... c c c c c c
Hvitost halvfet/mager ................................. c c c c c c
Kjøttpålegg, leverpostei ........................... c c c c c c
Rekesalat, italiensk o.l.  ........................... c c c c c c
På hvor mange brødskiver pr. uke har du i gjennomsnitt 













Makrell i tomat, røkt makrell ............... c c c c c c
Kaviar ........................................................................ c c c c c c
Sild/ansjos/sardiner .................................... c c c c c c
Laks/ørret (gravet/røkt) ................................... c c c c c c
Svolværpostei/Lofotpostei .................... c c c c c c
Krabbepålegg ..................................................... c c c c c c
Annet fiskepålegg .......................................... c c c c c c
Hvor mange poteter spiser du vanligvis (kokte, stekte, mos)?
(Sett ett kryss)
c Aldri/sjelden c 1 pr dag c 4+ pr dag
c 1-4 pr uke c 2 pr dag
c 5-6 pr. uke c 3 pr dag
Vi vil gjerne vite hvor ofte du pleier å spise fisk, og ber deg fylle ut 
spørsmålene om fiskeforbruk så godt du kan. Tilgangen på fisk kan 





hele året vinter vår sommer høst
Torsk, sei, hyse, lyr ................... c c c c c c
Steinbit, flyndre, uer ................. c c c c c c
Laks, ørret .......................................... c c c c c c
Kveite ...................................................... c c c c c c
Makrell .................................................. c c c c c c
Sild ........................................................... c c c c c c
Tunfisk (ikke på boks) .................... c c c c c c
Ferskvannsfisk (Abbor, 
gjedde, røye, sik, harr)....................... c c c c c c
Annen fisk .......................................... c c c c c c
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Dersom du spiser  fisk, hvor mye spiser du vanligvis pr. 
gang? (1 skive/stykke = 150 gram)
Kokt fisk (skive) ................................................ c 1 c 1,5 c 2 c 3+
Stekt fisk (stykke) ............................................. c 1 c 1,5 c 2 c 3+
Hvor mange ganger pr. år spiser du fiskeinnmat? 
(Sett ett kryss for hver linje)
aldri 1-3 4-6 7-9 10-15 16+
Rogn ........................................................................... c c c c c c
Fiskelever .............................................................. c c c c c c
Dersom du spiser fiskelever, hvor mange spiseskjeer pleier 
du å spise hver gang? (Sett ett kryss)
c 1 c 2 c 3-4 c 5-6 c 7+
Hvor ofte bruker du følgende typer fiskemat? 











Fiskekaker/pudding/boller ........................................................... c c c c c
Plukkfisk/fiskegrateng ........................................................... c c c c c
Frityrfisk/fiskepinner ............................................................... c c c c c
Andre fiskeretter .......................................................................... c c c c c
Hvor stor mengde pleier du vanligvis å spise av de ulike 
rettene? (Sett ett kryss for hver linje)
Fiskekaker/pudding/boller (stk.)  
(2 fiskeboller=1 fiskekake) .................................... c 1 c 2 c 3 c 4+
Plukkfisk, fiskegrateng (dl) ................... c 1-2 c 3-4 c 5+
Frityrfisk, fiskepinner (stk.) ................... c 1-2 c 3-4 c 5-6 c 7+
I tillegg til informasjon om fiskeforbruk er det viktig å få 
kartlagt hvilket tilbehør som blir servert til fisk. 











Smeltet/fast smør ........................................................... c c c c c
Smeltet/fast margarin/fett ....................................... c c c c c
Seterrømme (35%) .......................................................... c c c c c
Lettrømme (20%) .............................................................. c c c c c
Saus med fett (hvit/brun) ............................................. c c c c c
Saus uten fett (hvit/brun) ............................................. c c c c c
For de ulike typene tilbehør du bruker til fisk, vær vennlig å 
kryss av for hvor mye du vanligvis pleier å spise. 
Smeltet/fast smør (ss) .............. c ½ c 1 c 2 c 3 c 4+
Smeltet/fast margarin (ss) .... c ½ c 1 c 2 c 3 c 4+
Seterrømme (ss) ............................ c ½ c 1 c 2 c 3 c 4+
Lettrømme (ss) c ½ c 1 c 2 c 3 c 4+
Saus med fett (dl) c ¼ c ½ c ¾ c 1 c 2+
Saus uten fett (dl) c ¼ c ½ c ¾ c 1 c 2+
KJØTT
Hvor ofte spiser du følgende viltprodukter? 













Reinkjøtt .................................................................. c c c c c c
Andre matvarer fra rein (lever, nyre, 
margebein, hjerte, tunge, blod og annet) ..... c c c c c c
Elgkjøtt, andre matvarer fra elg ......... c c c c c c
Rype, annen viltfugl ..................................... c c c c c c
Hvor ofte spiser du følgende kjøtt- og fjærkreretter? 











Steik (okse, svin, får) .......................................................... c c c c c
Koteletter ................................................................................ c c c c c
Biff ................................................................................................ c c c c c
Kjøttkaker, karbonader ............................................... c c c c c
Pølser ........................................................................................ c c c c c
Gryterett, lapskaus ........................................................ c c c c c
Pizza med kjøtt ................................................................. c c c c c
Kylling ...................................................................................... c c c c c
Bacon, flesk ......................................................................... c c c c c
Innmat får/storfe .............................................................. c c c c c
Andre kjøttretter ............................................................... c c c c c
Hvor mange ganger i året spiser du hval-/selkjøtt? (Sett ett kryss)
aldri 1-3 4-6 7-9 10-15 16+
c c c c c c
Hvor mange ganger i året spiser du det brune kjøttet i 
krabbe (utenom krabbepålegg)? (Sett ett kryss)
aldri 1-3 4-6 7-9 10-15 16+
c c c c c c
Hvor mange ganger i året spiser du andre skalldyr (reker og 
skjell)? (Sett ett kryss)
aldri 1-3 4-6 7-9 10-15 16+
c c c c c c
Hvor mange måseegg eller egg fra annen sjøfugl spiser du i 
året? (Sett ett kryss)
aldri 1-3 4-6 7-9 10-15 16+
c c c c c c
Med tanke på de periodene av året der du spiser fisk, hvor 











Kokt torsk, sei, hyse, lyr .......................................... c c c c c
Stekt torsk, sei, hyse, lyr ......................................... c c c c c
Steinbit, flyndre, uer .................................................... c c c c c
Laks, ørret ............................................................................. c c c c c
Kveite ......................................................................................... c c c c c
Makrell ..................................................................................... c c c c c
Sild .............................................................................................. c c c c c
Tunfisk (ikke på boks) ....................................................... c c c c c
Ferskvannsfisk (Abbor, gjedde, røye, sik, harr) ....... c c c c c
Annen fisk ............................................................................. c c c c c
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Hvor mye bruker du vanligvis av disse sausene?
(Sett ett kryss for hver linje)
Brun saus (dl) .................................... c ¼ c ½ c ¾ c 1 c 2+
Sjysaus (dl) .......................................... c ¼ c ½ c ¾ c 1 c 2+
Tomatsaus (dl) ................................... c ¼ c ½ c ¾ c 1 c 2+
Saus med fløte/rømme (dl) ... c ¼ c ½ c ¾ c 1 c 2+
Dersom du spiser følgende retter, oppgi mengden du 
vanligvis spiser:  (Sett ett kryss for hver linje)
Steik (skiver) ......................................... c 1 c 2 c 3 c 4 c 5+
Koteletter(stk.) .................................... c ½ c 1 c 1 ½ c 2+
Kjøttkaker, karbonader (stk) ... c 1 c 2 c 3 c 4+
Pølser (stk à 150g) ............................ c ½ c 1 c 1 ½ c 2+
Gryterett, lapskaus (dl) .............. c 1-2 c 3 c 4 c 5+
Pizza m/kjøtt (stykke à 100 g) ... c 1 c 2 c 3 c 4+
Hvilke sauser bruker du til kjøttretter og pastaretter?










Brun saus .............................................................................. c c c c c
Sjysaus .................................................................................... c c c c c
Tomatsaus ............................................................................. c c c c c
Saus med fløte/rømme ............................................. c c c c c
ANDRE MATVARER
Hvor mange egg spiser du vanligvis i løpet av en uke
(stekte, kokte, eggerøre, omelett)? (Sett ett kryss)
c 0 c 1 c 2 c 3-4 c 5-6 c 7+
Hvor ofte spiser du iskrem (til dessert, Krone-is osv.)? 
Sett ett kryss for hvor ofte du spiser iskrem om sommeren, og ett kryss 











Om sommeren .................................................................. c c c c c
Resten av året .................................................................... c c c c c
Hvor mye is spiser du vanligvis pr. gang? (Sett ett kryss)
c 1 dl c 2 dl c 3 dl c 4+ dl
Hvor ofte spiser du bakevarer som boller, kaker,  













Gjærbakst (boller ol.) ....................................... c c c c c c
Wienerbrød, kringle ..................................... c c c c c c
Kaker .......................................................................... c c c c c c
Pannekaker........................................................... c c c c c c
Vafler .......................................................................... c c c c c c
Småkaker, kjeks ............................................... c c c c c c
Lefser, lomper .................................................... c c c c c c













Pudding sjokolade/karamell ................ c c c c c c
Riskrem, fromasj ............................................ c c c c c c
Kompott, fruktgrøt, hermetisk frukt ... c c c c c c
Jordbær (friske, frosne) ................................... c c c c c c
Andre bær (friske, frosne) ............................. c c c c c c
Hvor ofte spiser/drikker du ville bær, inkludert syltetøy og 













Multebær................................................................ c c c c c c
Tyttebær .................................................................. c c c c c c
Blåbær ...................................................................... c c c c c c
Krøkebær................................................................ c c c c c c
Andre bær ............................................................. c c c c c c













c c c c c c













Mørk sjokolade ................................................ c c c c c c
Lys sjokolade ..................................................... c c c c c c
Dersom du spiser sjokolade, hvor mye pleier du vanligvis å 
spise hver gang? Tenk deg størrelsen på en Kvikk-Lunsj sjokolade, 
og oppgi hvor mye du spiser i forhold til den.
c ¼ c ½ c ¾ c 1 c 1 ½ c 2+













Potetchips ............................................................. c c c c c c
Peanøtter ................................................................ c c c c c c
Andre nøtter ........................................................ c c c c c c
Annen snacks .................................................... c c c c c c
KOSTHOLD GJENNOM ULIKE LIVSFASER  
VARM MAT
Hvor mange ganger i løpet av en måned spiser du varm mat?
Til frokost Til middag
Til lunch Til kvelds
Det kan være vanskelig å huske eksakt hva du har spist gjennom tiden, 
men fyll ut sånn omtrent. 













Barndom ................................................................. c c c c c c
Ungdom 13-19................................................. c c c c c c
Voksen (før siste året) ....................................... c c c c c c
Når du har spist fisk, hvor ofte har du da spist fet fisk (laks, 













Barndom ................................................................. c c c c c c
Ungdom 13-19................................................. c c c c c c
Voksen (før siste året) ....................................... c c c c c c
7
Hvor ofte i nevnte livsfaser har du tatt tilskudd av tran/
omega-3/fiskeolje (flytende/kapsler/piller)?








Barndom vinter................................................................. c c c c c
Barndom resten av året............................................. c c c c c
Ungdom 13-19 vinter ................................................ c c c c c
Ungdom 13-19 resten av året ............................ c c c c c
Voksen vinter (før siste året)....................................... c c c c c
Voksen resten av året (før siste året)................... c c c c c
BARNEFAR
I forbindelse med sammenligning av ultralydmål, er det viktig å ha 
noen opplysninger om far til barnet i dette svangerskapet:
Hva var barnefars fødselsvekt som nyfødt baby?
 (Gram)    Vet ikke c 
Hva er barnefars høyde i dag? (cm) ........    Vet ikke c
Hvilket hjemmespråk har/hadde barnefar, hans foreldre og 
hans besteforeldre? (sett ett eller flere kryss)
Norsk Samisk Kvensk Annet Vet ikke
Dersom annet 
beskriv
Morfar .... c c c c c .....................................................
Mormor .. c c c c c .....................................................
Farfar...... c c c c c .....................................................
Farmor ... c c c c c .....................................................
Far.......... c c c c c .....................................................
Mor ........ c c c c c .....................................................
Barnefar .. c c c c c .....................................................
Hva regner barnefar seg selv som? (sett ett eller flere kryss)
Norsk Samisk Kvensk Annet Vet ikke Dersom annet beskriv
c c c c c ..............................................................................
Hva er barnefars, hans fars og hans mors etniske bakgrunn? 
(sett ett eller flere kryss)
Norsk Samisk Kvensk Annet Vet ikke
Dersom annet 
beskriv
Barnefars bakgrunn . c c c c c ......................................
Mors bakgrunn .......... c c c c c ......................................
Fars bakgrunn ............ c c c c c ......................................
ANGÅENDE SPØRSMÅLENE
Var noen av spørsmålene vanskelige eller nærgående? Hvis ja oppgi hvilke spørsmål og evt. kommentarer.































Hvor mange ganger i året har du spist hval-/selkjøtt? 
(Sett ett kryss pr. linje)
aldri 1-3 4-6 7-9 10-15 16+
Barndom ................................................................. c c c c c c
Ungdom 13-19................................................. c c c c c c
Voksen (før siste året) ....................................... c c c c c c
Hvor mange måseegg eller egg fra annen sjøfugl har du 
spist i året? (Sett ett kryss pr. linje)
aldri 1-3 4-6 7-9 10-15 16+
Barndom ................................................................. c c c c c c
Ungdom 13-19................................................. c c c c c c
Voksen (før siste året) ....................................... c c c c c c
Hvor mange ganger i året har du spist det brune kjøttet i 
krabbe (utenom krabbepålegg)? (Sett ett kryss pr. linje)
aldri 1-3 4-6 7-9 10-15 16+
Barndom ................................................................. c c c c c c
Ungdom 13-19................................................. c c c c c c
Voksen (før siste året) ....................................... c c c c c c
Hvor mange ganger i året har du spist fiskelever? 
(Sett ett kryss pr. linje)
aldri 1-3 4-6 7-9 10-15 16+
Barndom ................................................................. c c c c c c
Ungdom 13-19................................................. c c c c c c
Voksen (før siste året) ....................................... c c c c c c
Når du har spist fisk, hvor ofte har du da spist ferskvannsfisk 













Barndom ................................................................. c c c c c c
Ungdom 13-19................................................. c c c c c c
Voksen (før siste året) ....................................... c c c c c c
Hvor ofte har du spist fiskepålegg (Makrell, sild, ansjos, 
sardiner, røkt eller gravet laks/ørret, kaviar, fiskeleverpostei 
(Lofotpostei, Svolværpostei) krabbepålegg)?  













Barndom ................................................. c c c c c c c
Ungdom 13-19................................. c c c c c c c




Følgende opplysninger fylles ut i forbindelse 
med blodprøvetaking.
Dette skjema må følge blodprøven!
Skjemaet skal leses optisk. Vennligst bruk blå 






Urinprøve levert i dag: Ja: c	 Nei: c





stilling når blodprøven ble tatt
Måltid før blodprøven
Når spiste du siste måltid før blodprøven 
ble tatt: dag mnd
Dato.....................................................................................................................
Klokkeslett.....................................................................................................
Når drakk du siste kaffe før blodprøven 




Har du røykt i løpet av siste uke?




Hvor mye veier du i dag? (I hele kg) ..............................
Høyde og vekt
Er.vekten.tatt.i.dag?
c Ja c Nei
Hvor.ble.den.i.så.fall.tatt:







c Sittende c Liggende
Medisiner siste uken
Har du tatt medisiner i løpet av siste uke?

















(Ikke skriv her ‡) 
Er.høyden.målt.i.svangerskapet?
c Ja c Nei
Hvor høy er du (cm) .........................................................





















tran og fiskeolje siste uken
Har du brukt flytende tran/omega-3/fiskeolje i løpet av  
siste uke?
c Ja c Nei
Angi.mengde
c 1.ts c 1/2.ss c 1+.ss
Har du brukt kapsler/piller med tran/omega-3/fiskeolje i 
løpet av siste uke?
c Ja c Nei
Angi.mengde





(Ikke skriv her ‡) 
Preparatnavn:.....................................................................................................................................................
(Ikke skriv her ‡) 
Har du brukt andre kosttilskudd (vitaminer/mineraler) i løpet 
av siste uke?



































(Ikke skriv her ‡) 
Angi.mengde
c 1.stk c 2.stk c 3.stk
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Til deg  
som er gravid
Du må kontakt ditt nærmeste innsamlingssted for å avtale tid for oppstart. Du kan starte opp umiddelbart eller 
helst innen uke 20. Du kan også avtale å starte opp i forbindelse med ultralydundersøkelsen (ca. uke 18).
Innsamlingssted Telefonnummer
Kirkenes fødeavdeling 78 97 32 35
Hammerfest fødeavdeling 78 42 15 12
Alta Fødestue 78 45 54 00
Karasjok legesenter 78 46 85 00
Kautokeino legesenter 78 48 72 50
UNN barselavdeling 77 62 64 60
Sonjatun fødestue 77 77 08 25
Fødestua i Midt-Troms, Lenvik 77 87 14 90
Lofoten fødestue 76 06 01 22
Gynekologisk senter, Bodø 75 52 39 00
Ved oppstart:
Du skal måle blodtrykk og vekt, ta blodprøve og levere urinprøve. Vi ber deg derfor om å: 
Møte fastende. Om du ikke klarer å faste, kan du spise en lett, fettfattig frokost (brød, salat, grøt)  •	
uten kaffe. 
Ta med en morgenurinprøve tatt på følgende måte: Den første porsjon av urinstrålen kastes, den neste •	
porsjon urin samles i egnet beholder og den siste porsjon urin kastes.
Ta med ”Helsekort for gravide” da vi vil merke helsekortet med prosjektets ID•	
Før oppstart ber vi deg om å sende inn underskrevet samtykke (Miljøgifter i svangerskapet og i ammeperioden 
+ Morsmelksundersøkelsen) i vedlagte svarkonvolutt til Universitetet i Tromsø.
Dersom du har spørsmål, kan du ta kontakt med:
solrunn.hansen@ism.uit.no
Telefon 920 69 700





Til deg som vil delta
Det er for tiden økende fokus på miljøgifter og hvilke 
effekter disse har på omgivelsene og helsen til oss 
mennesker. Befolkningen i arktiske områder er spesielt 
utsatt siden miljøgifter fra den øvrige verden fraktes 
nordover til våre områder med globale hav- og luft-
strømmer. Nivået av miljøgifter i Norge er sammen-
lignet med andre land, generelt lave.
Kosten er den viktigste kilden for spredning av  
miljøgifter i tillegg til det vi finner i miljøet forøvrig.  
Vi er særlig sårbare for miljøgifter på fosterstadiet 
og i de første årene av livet. Fettløselige, organiske 
miljøgifter passerer lett fra mor til foster gjennom 
morkaka og navlesnora, og de utskilles også i mors-
melk. Nivåene av disse stoffene i mors blod gjennom 
svangerskapet og senere i brystmelk, gir indikasjoner 
på den risiko vi utsetter våre barn for. Målinger viser 
at de fleste miljøgifter heldigvis er på vei ned, men vi 
har mangelfull kunnskap om hvordan mennesker 
påvirkes over tid.
Vi har ennå liten informasjon om situasjonen i 
Nord-Norge. Vi ønsker derfor å gjennomføre en  
undersøkelse som skal måle nivåer av disse langsomt 
nedbrytbare stoffene hos om lag 1000 gravide og 
ammende mødre i vår landsdel. 
Hensikten er å: 
Kartlegge miljøgifter i mors blod, navlestrengs-•	
blod og morsmelk. 
Undersøke hvilken risiko gravide og nyfødte  •	
utsettes for gjennom påvirkning av miljøgifter og 
spesielt hva som tilføres gjennom kostholdet  
og morsmelk.
Se om det er noen sammenheng mellom miljøgifter •	
og helsen til mor og barn. 
Å lage grunnlag for retningslinjer i forebyggende •	
helsearbeid for å beskytte mennesker mot miljø-
gifter og spesielt kostholdsråd for gravide,  
ammende og kvinner i fertil alder. 
Lage grunnlag for oppfølgingsstudier til barna når •	
12-årsalder. 
Lagre prøvemateriale i biobank for å ha mulighet •	
til å analysere på ”nye” miljøgifter eller faktorer 
som kan virke beskyttende mot skadelige effekter 
av miljøgifter.
Prosjektet vil spesielt sammenligne den samiske  •	
og den norsk etniske befolkningen.
Tilleggsundersøkelse: Undersøke om det er  •	
forskjell mellom den samiske og den norske  
befolkning vedrørende fostermål utført ved  
ultralyd ved 18. svangerskapsuke. 
Forespørsel om å delta sendes til alle  
gravide som:
Har time hos jordmor eller time til rutineultralyd •	
Er i første halvdel av svangerskapet•	
Skal føde ved følgende fødesteder: Kirkenes, •	
Hammerfest, Alta, UNN, Sonjatun, Lenvik,  
Lofoten eller Bodø. 
Frivillig deltagelse
Deltakelse i undersøkelsen er frivillig og bygger på 
skriftlig informert samtykke. Alle data behandles 
strengt fortrolig, og resultater blir formidlet slik at 
ingen opplysninger kan føres tilbake til enkeltpersoner. 
Dersom du blir med, kan du trekke deg uansett tids-
punkt, og du kan be om at dine opplysninger og 
prøveresultater slettes inntil data er publisert.  
Du trenger ikke å begrunne hvorfor du trekker deg, 
og det medfører ingen konsekvenser for deg. Om du 
trekker deg i løpet av svangerskapet eller etter  
fødselen, ber vi deg om å gi tilbakemelding for å 
unngå utsendelse av nye spørreskjema/innsamlings-
utstyr og purring.
Forespørsel om deltakelse i forskningsprosjekt
Miljøgifter i svangerskapet  
og i ammeperioden
Hvis du blir med, spør vi deg om:
Spørreskjema:1. 
Å svare på et spørreskjema i første halvdel av •	
svangerskapet 
Prøver av deg til analyse av miljøgifter, fettstoffer 2. 
og hormoner:
Tungmetaller: Kvikksølv, bly, kadmium  
Organiske miljøgifter: DDT, HCH, Toxaphenes, 
HCB, PCB, dioksiner, bromerte flamme- 
hemmere, ftalater og PFOS
Jernlagre, kolesterol, triglyserider
Hormoner: FSH, LH, prolaktin, TSH, FT4, FT3, 
østradiol og progesteron
Blodprøve i første halvdel av svangerskapet, etter •	
fødsel og 6 uker etter fødsel
Navlestrengsblod ved fødsel•	
Hårprøve ved fødsel for biobank•	
Urinprøve ved hver blodprøvetaking til biobank•	
Blodtrykk, høyde og vekt i forbindelse med  •	
prøvetaking
At vi av ditt nyfødte barn kan få:3. 
Måle omkretsen rundt magen og genitale  •	
lengdemål
Avføringsprøve (mekonium) til biobank•	
Blodprøve av barnets hæl til eventuelt hormona-•	
nalyse og biobank. Blodprøven tas samtidig med 
rutineprøven ”Nyfødtscreening” 3. dag etter  
fødselen. Vi ber dersom det er nødvendig, å få 
stikke barnets hæl en ekstra gang for å få nok blod.
Morsmelkundersøkelsen:4. 
Å levere en morsmelksprøve samlet i løpet av  •	
barnets første levemåned, til analyse av miljøgifter 
I forbindelse med morsmelksundersøkelsen spør vi •	
deg også om å svare på spørreskjema når barnet 
er 1, 6 og 12 måneder og 2, 7 og 12 år gammel.  
Folkehelseinstituttet (FHI) er ansvarlig for denne  
delen av prosjektet. Personopplysninger utlevers  
til FHI, slik at de kan kontakte deg direkte for  
utlevering av utstyr og spørreskjema. Vi ber deg  
om å lese eget vedlagt informasjonsskriv med egen 
samtykkeerklæring.
Ditt samtykke: 5. 
Til å oppbevare prøvematerialet av deg selv og •	
barnet i biobank. Blod- og urinprøver, navlestrengs-
blod, mekonium og hårprøve vil lagres i en biobank 
til utgange av år 2022 ved Universitetet i Tromsø 
med prosjektansvarlig som ansvarlig. 
Til at prøvematerialet kan sendes avidentifisert  •	
til utlandet når det er nødvendig av hensyn til  
å få utført analyser av prøvene og for kvalitets-
kontrollanalyser (Canada).
Innhenting av opplysninger:6. 
Tillatelse til innhenting av nødvendige journal-•	
opplysninger om deg og ditt barn i forbindelse 
med svangerskapet og fødselen. Kopi av svanger-
skapsjournal, ultralydskjema, barnets epikrise som 
sendes til helsestasjonen og skjema til Medisinsk 
Fødselsregister. Alle opplysninger behandles etter 
at personopplysninger er fjernet og erstattet med 
et ID-nummer før utlevering til Universitetet. 
Tillatelse til å koble innsamlede opplysninger  7. 
om deg:
Fra denne delen av prosjektet mot data fra Mors-•	
melksundersøkelsen og Mor-/barnundersøkelsen.
Mot Medisinsk Fødselsregister vedrørende data fra •	
pågående og eventuelt tidligere svangerskap og fødsler.
Mot Norsk pasientregister som registrerer diagnoser •	
barnet ditt har fått ved innleggelse på sykehus. 
Mot Nyfødtscreeningregisteret som gir prøvesvar •	
på barnets stoffskifte (TSH).
Datatilsynet har godkjent disse koblingene.•	
Kontakte deg senere for å:8. 
Invitere dere til ekstra undersøkelse når barnet er •	
blitt eldre. Du forplikter deg ikke til å delta i dette, 
men kan ta stilling til dette når du får invitasjonen 
som vil inneholde detaljert informasjon om hva vi 
ønsker å undersøke.
Utstyr, ID-nummer
Ditt og barnets navn og fødselsdato er byttet ut  
(avidentifisert) med et nummer når det brukes i  
forskning. Ved oppstart får du utlevert alt utstyr 
merket med et ID-nummer. Både prøver og innsamlet 
informasjon blir derfor avidentifisert på innsamlings-
stedet dersom du har med ID-merket utstyr. Om du 
ikke har med forhåndsmerket utstyr, skjer avidentifi-
seringen etter ankomst Universitetet i Tromsø. Data 
vil anonymiseres etter prosjektslutt år 2022. 
Din sikkerhet og tilbakemelding
Opplysninger du gir og svar på prøver du tar, blir 
kun brukt til forskning. Vi forplikter oss til å gi til-
bakemelding til deg dersom du ønsker svar på dine 
egne blodprøver. Du får svar på for eksempel nivåer 
av miljøgifter, hormoner og fettstoffer. Vi gir deg  
automatisk svar på avvikende fettstoffer og hormon-
prøver vedrørende stoffskifte. Din fastlege får også 
prøvesvar dersom du tillater det, og fastlege kan gi 
deg videre oppfølging. Det tar noen måneder før  
resultatene foreligger pga. tidkrevende analyser.  
Vi lager rapporter fra prosjektet, og hvis du ønsker det, 
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